Mutations and Variants in ABCD1

The ALD database reports all mutations and variations conform to the nomenclature recommended by the Human Genome Variation Society. All mutations and variants, including those already published, are annotated using the “Alamut Visual” software package. The variants (VUS (variant of unknown significance), polymorphisms and synonymous variants) reported come from the genome Aggregation Database (gnomAD). The dataset spans 123,136 exomes and 15,496 genomes from unrelated individuals sequenced as part of various disease-specific and population genetic studies. This work has also identified variants in the ABCD1 gene, which are included in the ALD database.
The ALD database is a community-driven project. Its strength lies in the sharing of information through collaborations with many diagnostic centers. If your diagnostic laboratory uses the ALD database as a reference guide, please share your ABCD1 mutations identified with the ALD database to make them available to others (your contribution will be acknowledged).
Back to information

Chromosome position Variant Consequence Exon Remark
152990663 c.-59C>T 5′ UTR Benign, based on its frequency of 11/150 control alleles (48) and 1978/21253 (X:152990663 C/T) individuals.
152990698 c.-24_57delinsA p.0?
(no translation initiation)
5′ UTR Pathogenic, identified in ALD patient (33).
152990700 c.-22C>T p.0?
upstream ATG (out of frame)
5′ UTR Pathogenic, identified in ALD patient (32). Affects ALDP stability in patient cells (32).
152990702 c.-20C>T 5′ UTR Benign, based on its frequency of 14/1825 control alleles (X:152990702 C/T).
152990705 c.-17_8del p.0?
(no translation initiation)
5′ UTR Pathogenic, identified in 21 ALD patients (extensive pedigree analysis (45)). No detectable ALDP in patient cells (45).
152990722 c.1A>G p.Met1Val
(no translation initiation)
exon 1 Pathogenic, identified in 21 ALD patients (32, 102, 139, 141). No detectable ALDP in patient cells (102, 139, 141).
152990722 c.1A>T p.Met1Val
(no translation initiation)
exon 1 Pathogenic, identified in ALD patient (160).
152990723 c.2T>A p.Met1Lys
(no translation initiation)
exon 1 Pathogenic, identified in 5 ALD patients (58). No detectable ALDP in patient cells (58).
152990724 c.3G>A p.Met1Ile
(no translation initiation)
exon 1 Pathogenic, identified in ALD patient (33).
152990724 c.3G>C p.Met1Ile
(no translation initiation)
exon 1 Pathogenic, identified in ALD patient (73).
152990740 c.19C>T p.Pro7Ser exon 1 VUS (X:152990740 C/T) frequency 1/21371 control alleles
152990751 c.30G>A p.Trp10* exon 1 Pathogenic, identified in 3 ALD patients (7, 58). No detectable ALDP in patient cells (7).
152990751 c.30G>C p.Trp10Cys exon 1 VUS (X:152990751 G/C) frequency 1/81065 control alleles
152990753 c.32G>C p.Arg11Pro exon 1 VUS (X:152990753 G/C) frequency 1/21315 control alleles
152990757 c.36dupG p.Asn13Glufs*182 exon 1 Pathogenic, identified in ALD patient (32). Deleterious mutation.
152990759 c.38A>C p.Asn13Thr exon 1 Benign variant based on 279/103021 control alleles (X:152990759 A/C), confirmed by biochemical testing (48).
152990761 c.40A>G p.Thr14Ala exon 1 VUS (X:152990761 A/G) frequency 6/82276 control alleles..
152990762 c.41C>G p.Thr14Arg exon 1 Benign variant based on 39/103760 control alleles (X:152990762 C/G).
152990767 c.[46A>T; 706C>T] p.[Lys16*; Arg236Cys] exon 1 Pathogenic, identified in 2 ALD patients (33). p.Lys16* is a deleterious mutation. Clinical significance of p.Arg236Cys is unclear.
152990771 c.50G>A p.Arg17His exon 1 Benign variant, confirmed by biochemical testing (139).
152990772 c.51_54dup p.Ala19Hisfs*177 exon 1 Pathogenic, identified in ALD patient (58). No detectable ALDP in patient cells (58).
152990776 c.55G>T p.Ala19Ser exon 1 Benign variant, confirmed by biochemical testing (104).
152990778 c.57del p.Val20Cysfs*48 exon 1 Pathogenic, identified in ALD patient (16). No detectable ALDP in patient cells (146).
152990788 c.67_83del p.Ala23Serfs*166 exon 1 Pathogenic, identified in 2 ALD patients (71, 150). Deleterious mutation.
152990801 c.80A>C p.Tyr27Ser exon 1 Probably pathogenic, identified in ALD patient (181).
152990811 c.90C>T p.His30His exon 1 Synonymous (X:152990811 C/T) frequency 5/108570 individuals..
152990813 c.92A>G p.Lys31Arg exon 1 VUS (X:152990813 A/G) frequency 9/88297 individuals.
152990816 c.95T>C p.Val32Ala exon 1 VUS (X:152990816 T/C) frequency 1/88007 control alleles
152990818 c.97_100del p.Tyr33Profs*34 exon 1 Pathogenic, identified in ALD patient (48). Deleterious mutation.
152990820 c.99C>A p.Tyr33* exon 1 Pathogenic, identified in ALD patient (105). Deleterious mutation.
152990820 c.99_102del p.Pro34Trpfs*33 exon 1 Pathogenic, identified in ALD patient (100). Deleterious mutation.
152990821 c.100C>T p.Pro34Ser exon 1 VUS (X:152990821 C/T).
152990823 c.102delinsAT p.Leu35Phefs*160 exon 1 Pathogenic, identified in ALD patient (24). Deleterious mutation.
152990823 c.102dup p.Val36Glyfs*159 exon 1 Pathogenic, identified in ALD patient (120). Deleterious mutation.
152990829 c.108G>A p.Val36Val exon 1 Synonymous (X:152990829 G/A).
152990830 c.109C>G p.Arg37Gly exon 1 Pathogenic, identified in ALD patient (32).
152990831 c.110_17del p.Arg37Profs*155 exon 1 Pathogenic, identified in 2 ALD patients (33, 72). Deleterious mutation.
152990833 c.112C>T p.Gln38* exon 1 Pathogenic, identified in ALD patient (33). Deleterious mutation.
152990836 c.115_31delinsGCA p.Cys39Lysfs*151 exon 1 Pathogenic, identified in ALD patient (60). No detectable ALDP in patient cells (60).
152990840 c.119_47del p.Leu40Argfs*145 exon 1 Pathogenic, identified in ALD patient (52). Deleterious mutation.
152990846 c.125delC p.Pro42Argfs*26 exon 1 Pathogenic, identified in ALD patient (96). Deleterious mutation.
152990846 c.125_26insC p.Ala43Glyfs*152 exon 1 Pathogenic, identified in 3 ALD patients (33, 49). Deleterious mutation.
152990859 c.138_39insT p.Gln47Serfs*148 exon 1 Pathogenic, identified in ALD patient (7). Deleterious mutation.
152990860 c.139C>T p.Gln47* exon 1 Pathogenic, identified in 4 ALD patients (33, 58, 105). Deleterious mutation. No detectable ALDP in patient cells (58).
152990864 c.143C>T p.Ala48Val exon 1 VUS (X:152990864 C/T) frequency 2/21376 individuals.
152990866 c.145_46insCGAC p.Ala50Thrfs*146 exon 1 Pathogenic, identified in ALD patient (63). No detectable ALDP in patient cells (63).
152990868 c.147C>T p.Pro49Pro exon 1 Synonymous (X:152990868 C/T).
152990871 c.150dup p.Gly51Argfs*144 exon 1 Pathogenic, identified in ALD patient (58). Deleterious mutation. No detectable ALDP in patient cells (58).
152990875 c.154G>T p.Glu52* exon 1 Pathogenic, identified in ALD patient (38). Deleterious mutation.
152990875 c.154dup p.Glu52Glyfs*143 exon 1 Pathogenic, identified in ALD patient (33). Deleterious mutation.
152990876 c.155_56insG p.Pro53Alafs*142 exon 1 Pathogenic, identified in ALD patient (33). Deleterious mutation.
152990884 c.163C>T p.Gln55* exon 1 Pathogenic, identified in ALD patient (100). Deleterious mutation.
152990892 c.171C>G p.Ala57Ala eonx 1 Synonymous (X:152990892 C/G).
152990894 c.173C>G p.Ser58Cys exon 1 VUS (X:152990894 C/G) frequency 3/103209 individuals.
152990894 c.173C>T p.Ser58Phe exon 1 VUS (X:152990894 C/T) frequency 9/103209 individuals.
152990902 c.181G>A p.Ala61Thr exon 1 VUS (X:152990902 G/A) frequency 18/127289 individuals..
152990907 c.186G>A p.Ala62Ala exon 1 Synonymous (X:152990907 G/A).
152990927 c.206G>A p.Arg69Gln exon 1 VUS (X:152990927 G/A) frequency 1/21537 individuals.
152990929 c.208G>A p.Val70Ile exon 1 VUS (X:152990929 G/A) frequency 2/120391 individuals.
152990941 c.220C>T p.Arg74Trp exon 1 Pathogenic, identified in 9 ALD patients (32, 88, 97, 141). Reduced (7% of control cells) ALDP in patient cells (97).
152990944 c.223_40dup p.Trp77_Leu82dup exon 1 Pathogenic, identified in ALD patient (58). No detectable ALDP in patient cells (58).
152990946 c.225C>T p.Leu75Leu exon 1 Synonymous (X:152990946 C/T).
152990946 c.225_42del p.Trp77_Leu82del exon 1 Pathogenic, identified in 2 ALD patients (58, 111). No detectable ALDP in patient cells (58).
152990952 c.231G>T p.Trp77Cys exon 1 VUS (X:152990952 G/T).
152990953 c.232_40del p.Arg80_Leu82del exon 1 Pathogenic, identified in 2 ALD patients (38, 58). No detectable ALDP in patient cells (58).
152990955 c.234_42del p.Arg80_Leu82del exon 1 Pathogenic, identified in ALD patient (33). Deleterious mutation.
152990955 c.234_42dupCCTGCGGCT p.Arg80_Leu82dup exon 1 Pathogenic, identified in 5 ALD patients (33, 186). Deleterious mutation.
152990961 c.240_41insTTTGCG p.Arg80_Leu81insPheAla exon 1 Pathogenic, identified in ALD patient (27). Deleterious mutation.
152990961 c.240_41insTCCTGCGGC p.Arg80_Leu81insSerCysGly exon 1 Pathogenic, identified in 2 ALD patients (64, 132). Deleterious mutation.
152990962 c.241C>G p.Leu81Val exon 1 VUS (X:152990962 C/G) frequency 2/109810 individuals.
152990964 c.244_245insCTGCGGCTC p.Leu81_Leu82insProAlaAla exon 1 Pathogenic, identified in 4 ALD patients (28, 33). Deleterious mutation. (Originally reported as: c.243-44insCCTGCGGCT)
152990969 c.248del p.Phe83Serfs*20 exon 1 Pathogenic, identified in ALD patient (33). Deleterious mutation.
152990970 c.249C>T p.Phe83Phe exon 1 Synonymous (X:152990970 C/T) frequency 49/130671 individuals..
152990971 c.250C>T p.Pro84Ser exon 1 Pathogenic, identified in ALD patient (90).
152990972 c.251C>T p.Pro84Leu exon 1 Pathogenic, identified in ALD patient (33).
152990974 c.253dup p.Arg85Profs*110 exon 1 Pathogenic, identified in 16 ALD patients (33, 49, 60, 62, 119, 138, 155). No detectable ALDP in patient cells (60).
152990974 c.253del p.Arg85Glyfs*18 exon 1 Pathogenic, identified in ALD patient (58). Deleterious mutation.
152990975 c.254G>T p.Arg85Leu exon 1 VUS (X:152990975 G/T).
152990977 c.256G>A p.Val86Ile exon 1 VUS (X:152990977 G/A).
152990979 c.258C>T p.Val86Val exon 1 Synonymous (X:152990979 C/T) frequency 113/138493 individuals..
152990979 c.258C>G p.Val86Val exon 1 Synonymous (X:152990979 C/G).
152990985 c.264C>A p.Cys88* exon 1 Pathogenic, identified in ALD patient (33). Deleterious mutation.
152990985 c.264C>G p.Cys88Trp exon 1 Pathogenic, identified in 3 ALD patients (63). No detectable ALDP in patient cells (63).
152990986 c.265C>T p.Arg89Trp exon 1 VUS (X:152990986 C/T).
152990987 c.266G>A p.Arg89Gln exon 1 VUS (X:152990987 G/A) frequency 2/21458 individuals.
152990989 c.268G>A p.Glu90Lys exon 1 Pathogenic, identified in 2 ALD patients (49).
152990989 c.268G>T p.Glu90* exon 1 Pathogenic, identified in ALD patient (141). No detectable ALDP in patient cells (141).
152990991 c.270_71del p.Glu90Aspfs*104 exon 1 Pathogenic, identified in 2 ALD patients (93). Deleterious mutation.
152990995 c.274G>A p.Gly92Arg exon 1 Benign variant based on its frequency of 17/149988 individuals (X:152990995 G/A).
152990995 c.274_311del p.Gly92Hisfs*90 exon 1 Pathogenic, identified in 3 ALD patients (4, 158). Deleterious mutation.
152990996 c.275G>T p.Gly92Val exon 1 VUS (X:152990996 G/T).
152990998 c.277del p.Leu93Cysfs*10 exon 1 Pathogenic, identified in ALD patient (16). Deleterious mutation.
152990998 c.277_96dup p.Ala100Cysfs*10 exon 1 Pathogenic, identified in 2 ALD patients (111, 149). Deleterious mutation.
152991001 c.280_81insGAGACGGGGCTG p.Leu94delinsArgAspGlyAlaVal exon 1 Pathogenic, identified in ALD patient (96).
152991005 c.284C>A p.Ala95Asp exon 1 Pathogenic, identified in 6 ALD patients. No detectable ALDP in patient cells (109).
152991008 c.287_88insCC p.His97Argfs*7 exon 1 Pathogenic, identified in ALD patient (40). Deleterious mutation.
152991011 c.290A>C p.His97Pro exon 1 Pathogenic, identified in 4 ALD patients (33, 142, 170).
152991011 c.290A>T p.His97Leu exon 1 Benign, confirmed by biochemical testing (109).
152991013 c.292T>C p.Ser98Pro exon 1 Pathogenic, identified in ALD patient (58). Reduced ALDP in patient cells (58).
152991014 c.293C>A p.Ser98* exon 1 Pathogenic, identified in 2 ALD patients (32, 105). Deleterious mutation.
152991014 c.293C>T p.Ser98Leu exon 1 Pathogenic, identified in 11 ALD patients (7, 33, 48, 49, 58, 98). Normal ALDP level in patient cells (7), but non-functional.
152991014 c.293C>G p.Ser98Trp exon 1 Pathogenic, identified in 3 ALD patients (41).
152991015 c.294G>T p.Ser98Ser exon 1 Synonymous (X:152991015 G/T).
152991015 c.294_95insC p.Ala99Argfs*96 exon 1 Pathogenic, identified in ALD patient (38). Deleterious mutation.
152991016 c.295_98dup p.Ala100Glyfs*96 exon 1 Pathogenic, identified in ALD patient (58). Deleterious mutation.
152991017 c.296C>A p.Ala99Asp exon 1 Pathogenic, identified in ALD patient (48).
152991019 c.298del p.Ala100Profs*3 exon 1 Pathogenic, identified in ALD patient (28). Deleterious mutation.
152991021 c.300C>G p.Ala100Ala exon 1 Synonymous (X:152991021 C/G).
152991022 c.301T>A p.Lys101Met exon 1 Pathogenic, identified in ALD patient (33).
152991026 c.305T>A p.Val102Glu exon 1 Pathogenic, identified in ALD patient (60).
152991030 c.309C>G p.Ser103Arg exon 1 Pathogenic, identified in 2 ALD patients (29, 53). Reduced ALDP in patient cells (53).
152991031 c.310C>T p.Arg104Cys exon 1 Pathogenic, identified in 13 ALD patients (13, 16, 33, 42, 62, 97, 125, 146). Reduced ALDP (35% of control cells) in patient cells (33, 97, 146).
152991032 c.311G>A p.Arg104His exon 1 Pathogenic, identified in 9 ALD patients (4, 32, 33, 47, 49, 132, 137).
152991032 c.311G>T p.Arg104Leu exon 1 Pathogenic, identified in ALD patient (33).
152991032 c.311G>C p.Arg104Pro exon 1 Pathogenic, identified in ALD patient (114).
152991034 c.313A>C p.Thr105Pro exon 1 Pathogenic, identified in 4 ALD patients (33, 38, 158).
152991035 c.314C>T p.Thr105Ile exon 1 Pathogenic, identified in ALD patient (7). No detectable ALDP in patient cells (7).
152991040 c.319del p.Leu107Cysfs*91 exon 1 Pathogenic, identified in ALD patient (33). Deleterious mutation.
152991041 c.320T>C p.Leu107Pro exon 1 Pathogenic, identified in 6 ALD patients (15, 178).
152991041 c.320T>G p.Leu107Arg exon 1 Pathogenic, identified in ALD patient (88).
152991042 c.321G>A p.Leu107Leu exon 1 Synonymous (X:152991042 G/A).
152991044 c.323C>A p.Ser108* exon 1 Pathogenic, identified in 4 ALD patients (33, 56, 60, 93). No detectable ALDP in patient cells (60).
152991044 c.[323C>A; 775C>T] p.[Ser108*; Arg259Trp] exon 1 Pathogenic, identified in ALD patient (86). p.Ser108* is deleterious.
152991044 c.323C>T p.Ser108Leu exon 1 Pathogenic, identified in 12 ALD patients (33, 34, 53, 62, 90, 137, 156). Normal ALDP level in patient cells (53), but non-functional.
152991044 c.323C>G p.Ser108Trp exon 1 Pathogenic, identified in 3 ALD patients (7, 53). Reduced ALDP in patient cells (7).
152991046 c.325del p.Val109Cysfs*89 exon 1 Pathogenic, identified in 3 ALD patients (32). Deleterious mutation.
152991047 c.326T>C p.Val109Ala exon 1 VUS (X:152991047 T/C).
152991058 c.337delC p.Arg113Alafs*85 exon 1 Pathogenic, identified in 7 ALD patients (32, 49, 62, 141). No detectable ALDP in patient cells (49, 97, 141).
152991058 c.337C>T p.Arg113Cys exon 1 Pathogenic, identified in 6 ALD patients (32, 49). Normal ALDP level in patient cells (32, 49), but non-functional.
152991059 c.338G>C p.Arg113Pro exon 1 Pathogenic, identified in 4 ALD patients (33, 49).
152991062 c.341T>C p.Leu114Pro exon 1 Pathogenic, identified in 2 ALD patients (33, 53). Reduced ALDP in patient cells (53).
152991067 c.346G>T p.Gly116* exon 1 Pathogenic, identified in 2 ALD patients (137). Deleterious mutation.
152991067 c.346G>A p.Gly116Arg exon 1 Pathogenic, identified in 10 ALD patients (7, 29, 32, 33, 58, 145). Reduced ALDP in patient cells (7).
152991067 c.346G>C p.Gly116Arg exon 1 Pathogenic, identified in ALD patient (33).
152991068 c.347_48delGAinsAT p.Gly116Asp exon 1 Pathogenic, identified in ALD patient (120).
152991068 c.347G>A p.Gly116Glu exon 1 Pathogenic, identified in 3 ALD patients (57, 87, 88)
152991073 c.352delCT p.Leu118Glyfs*76 exon 1 Pathogenic, identified in ALD patient (52). Deleterious mutation.
152991076 c.355del p.Ala119Profs*79 exon 1 Pathogenic, identified in 2 ALD patients (178). Deleterious mutation.
152991076 c.355G>T p.Ala119Ser exon 1 VUS (X:152991076 G/T).
152991077 c.356C>A p.Ala119Asp exon 1 Pathogenic, identified in 2 ALD patients (33).
152991079 c.358C>G p.Arg120Gly exon 1 VUS (X:152991079 C/G).
152991080 c.359G>A p.Arg120His exon 1 VUS (X:152991080 G/A).
152991080 c.359G>C p.Arg120Pro exon 1 Pathogenic, identified in 5 ALD patients (60). Normal ALDP level in patient cells (60), but non-functional.
152991089 c.368C>T p.Ala123Val exon 1 This was a sequence error in original sequence (18)
152991092 c.371G>C p.Arg124Pro exon 1 Pathogenic, identified in ALD patient (33).
152991092 c.371G>A p.Arg124His exon 1 VUS (X:152991092 G/A) frequency 1/21546 control alleles
152991096 c.375_78del p.Lys125Asnfs*72 exon 1 Pathogenic, identified in ALD patient (123). Deleterious mutation.
152991102 c.381G>A p.Pro127Pro exon 1 Synonymous (X:152991102 G/A).
152991102 c.381G>T p.Pro127Pro exon 1 Synonymous (X:152991102 G/T).
152991103 c.382C>T p.Arg128Trp exon 1 VUS (X:152991103 C/T).
152991104 c.383G>C p.Arg128Pro exon 1 VUS (X:152991104 G/C) frequency 3/171978 control alleles.
152991104 c.383G>A p.Arg128Gln exon 1 VUS (X:152991104 G/A) frequency 3/193580 control alleles.
152991106 c.385dup p.Ala129Glyfs*66 exon 1 Pathogenic, identified in 2 ALD patients (59, 64). Deleterious mutation.
152991108 c.387del p.Phe130Leufs*68 exon 1 Pathogenic, identified in ALD patient (29). Deleterious mutation.
152991110 c.389T>G p.Phe130Cys exon 1 VUS (X:152991110 T/G) frequency 1/21683 control alleles
152991112 c.391G>C p.Gly131Arg exon 1 VUS (X:152991112 G/C) frequency 1/172406 control alleles
152991113 c.392G>T p.Gly131Val exon 1 Benign, based on its frequency of 13/171567 control alleles (X:152991113 G/T).
152991116 c.395G>A p.Trp132* exon 1 Pathogenic, identified in 3 ALD patients (71, 94, 150). Deleterious mutation.
152991117 c.396G>A p.Trp132* exon 1 Pathogenic, identified in 8 ALD patients (33, 52, 59, 64, 100, 132, 137). Deleterious mutation.
152991118 c.397C>T p.Gln133* exon 1 Pathogenic, identified in 8 ALD patient (16, 32, 33, 49, 141). No detectable ALDP in patient cells (49, 141).
152991122 c.401T>G p.Leu134Arg exon 1 Pathogenic, identified in ALD patient (95).
152991122 c.401_05delinsAGCATT p.Leu134Glnfs*61 exon 1 Pathogenic, identified in ALD patient (19). Deleterious mutation.
152991127 c.406C>T p.Gln136* exon 1 Pathogenic, identified in ALD patient (33). Deleterious mutation.
152991128 c.407A>G p.Gln136Arg exon 1 VUS (X:152991128 A/G) frequency 1/172655 control alleles
152991131 c.410G>A p.Trp137* exon 1 Pathogenic, identified in 3 ALD patients (96, 98). Deleterious mutation.
152991132 c.411G>A p.Trp137* exon 1 Pathogenic, identified in 6 ALD patients (16, 33, 49, 58, 62). No detectable ALDP in patient cells (49, 146).
152991132 c.411G>T p.Trp137Cys exon 1 Pathogenic, identified in 3 ALD patients (32). No detectable ALDP in patient cells (32).
152991132 c.411_12insC p.Leu138Profs*57 exon 1 Pathogenic, identified in ALD patient (100). Deleterious mutation.
152991133 c.412_23del p.Leu139_Leu142del exon 1 Pathogenic, identified in ALD patient (15). Deleterious mutation.
152991133 c.412_14del p.Leu139del exon 1 Pathogenic, identified in 2 ALD patients (52, 96).
152991135 c.414C>T p.Leu138Leu exon 1 Synonymous (X:152991135 C/T).
152991141 c.420C>A p.Ile140Ile exon 1 Synonymous (X:152991141 C/A).
152991141 c.420C>T p.Ile140Ile exon 1 Synonymous (X:152991141 C/T).
152991142 c.421G>A p.Ala141Thr exon 1 Pathogenic, identified in 16 ALD patients (13, 59, 64, 88, 93, 111, 137, 174, 178).
152991143 c.422C>T p.Ala141Val exon 1 Pathogenic, identified in 2 ALD patients (33).
152991145 c.424del p.Leu142Serfs*56 exon 1 Pathogenic, identified in ALD patient (125). Deleterious mutation.
152991145 c.424C>G p.Leu142Val exon 1 VUS (X:152991145 C/G) frequency 3/196447 individuals.
152991147 c.426C>T p.Leu142Leu exon 1 Synonymous (X:152991147 C/T).
152991148 c.427C>G p.Pro143Ala exon 1 Pathogenic, identified in 3 ALD patients (98).
152991148 c.427C>T p.Pro143Ser exon 1 Pathogenic, identified in 5 ALD patients (33, 34, 38, 49, 88).
152991149 c.428C>A p.Pro143His exon 1 Pathogenic, identified in 2 ALD patients (58, 98). Normal ALDP level in patient cells (58), but non-functional.
152991149 c.428C>T p.Pro143Leu exon 1 Pathogenic, identified in ALD patient (33).
152991153 c.432_46delinsCCC p.Thr145_Ser149delinsPro exon 1 Pathogenic, identified in ALD patient (58). No detectable ALDP in patient cells (58).
152991156 c.435C>G p.Thr145Thr exon 1 Synonymous (X:152991156 C/G).
152991157 c.436T>A p.Phe146Ile exon 1 Benign variant based on its frequency 26/197980 control alleles (X:152991157 T/A).
152991157 c.436T>G p.Phe146Val exon 1 VUS (X:152991157 T/G).
152991160 c.439G>A p.Val147Ile exon 1 VUS (X:152991160 G/A) frequency 2/176480 control alleles.
152991160 c.439_41del p.Val147del exon 1 Pathogenic, identified in ALD patient (33). Deleterious mutation.
152991161 c.440T>G p.Val147Gly exon 1 Pathogenic, identified in ALD patients (32). Normal ALDP level in patient cells (32), but non-functional.
152991161 c.442_444delinsTGTTGA p.Asn148_Thr745delinsCys exon 1 Pathogenic, identified in ALD patient (145). Deleterious mutation.
152991163 c.441_442dup p.Val147_Asn148insIle exon 1 Pathogenic, identified in ALD patient (58). Deleterious mutation.
152991163 c.442A>G p.Asn148Asp exon 1 Pathogenic, identified in 2 ALD patients (32, 86).
152991163 c.442A>T p.Asn148Tyr exon 1 Pathogenic, identified in ALD patient (60). Normal ALDP level in patient cells (60), but non-functional.
152991164 c.443A>G p.Asn148Ser exon 1 Pathogenic, identified in 12 ALD patients (7, 8, 24, 33, 38, 60, 93, 98, 158). Normal ALDP level in patient cells (7), but non-functional.
152991167 c.446G>A p.Ser149Asn exon 1 Pathogenic, identified in 25 ALD patients (16, 32, 49, 97, 141, 146). Reduced ALDP expression (77% of control cells) in patient cells (97).
152991175 c.454C>A p.Arg152Ser exon 1 Pathogenic, identified in 5 ALD patients (29, 33, 49).
152991175 c.454C>T p.Arg152Cys exon 1 Pathogenic, identified in 13 ALD patients (7, 13, 32, 33, 49, 52, 63, 88, 168). Normal ALDP level in patient cells (7, 32, 49, 52), but non-functional.
152991176 c.455G>A p.Arg152His exon 1 VUS (X:152991176 G/A) frequency 1/177452 control alleles
152991176 c.455G>C p.Arg152Pro exon 1 Pathogenic, identified in 2 ALD patients (16, 32). Normal ALDP level in patient cells (32), but non-functional.
152991176 c.455G>T p.Arg152Leu exon 1 Pathogenic, identified in 6 ALD patients (32, 33, 49, 52, 58). Reduced ALDP expression in patient cells (32, 49).
152991182 c.461T>C p.Leu154Pro exon 1 Pathogenic, identified in 3 ALD patients (33, 88).
152991183 c.462_81del p.Glu155Valfs*33 exon 1 Pathogenic, identified in ALD patient (44). Deleterious mutation.
152991190 c.469C>T p.Gln157* exon 1 Pathogenic, identified in 4 ALD patients (16, 32, 146). Deleterious mutation. No detectable ALDP in patient cells (146).
152991192 c.471A>G p.Gln157Gln exon 1 Synonymous (X:152991192 A/G).
152991193 c.472C>G p.Leu158Val exon 1 VUS (X:152991193 C/G) frequency 2/177870 individuals.
152991194 c.473T>C p.Leu158Pro exon 1 Pathogenic, identified in 2 ALD patients (33, 125).
152991196 c.475G>A p.Ala159Thr exon 1 VUS (X:152991196 G/A) frequency 2/199788 individuals.
152991197 c.476C>G p.Ala159Gly exon 1 VUS (X:152991197 C/G) frequency 6/177941 individuals.
152991197 c.476_99del p.Ala159_Leu166del exon 1 Pathogenic, identified in 2 ALD patients (33, 96).
152991198 c.477C>T p.Ala159Ala exon 1 Synonymous (X:152991198 C/T).
152991200 c.479T>C p.Leu160Pro exon 1 Pathogenic, identified in 3 ALD patients (70, 111, 158).
152991202 c.481T>C p.Ser161Pro exon 1 Pathogenic, identified in ALD patient (49).
152991203 c.482C>A p.Ser161* exon 1 Pathogenic, identified in 2 ALD patients (29, 88). Deleterious mutation.
152991204 c.483G>A p.Ser161Ser exon 1 Synonymous (X:152991204 G/A).
152991208 c.487C>G p.Arg163Gly exon 1 Pathogenic, identified in ALD patient (163).
152991209 c.488G>A p.Arg163His exon 1 Pathogenic, identified in ALD patient (16). No detectable ALDP in patient cells (32).
152991209 c.488G>T p.Arg163Leu exon 1 Pathogenic, identified in 2 ALD patients (33, 116).
152991209 c.488G>C p.Arg163Pro exon 1 Pathogenic, identified in 9 ALD patients (33, 41, 49, 57).
152991214 c.493C>T p.Arg165Cys exon 1 VUS (X:152991214 C/T) frequency 3/178141 individuals.
152991215 c.494del p.Arg165Leufs*33 exon 1 Pathogenic, identified in ALD patient (52). Deleterious mutation.
152991216 c.495_514del p.Leu166Profs*22 exon 1 Pathogenic, identified in ALD patient (33). Deleterious mutation.
152991217 c.496_97insG p.Leu166Argfs*29 exon 1 Pathogenic, identified in 3 ALD patients (61). Deleterious mutation.
152991219 c.498G>T p.Leu166Leu exon 1 Synonymous (X:152991219 G/T).
152991225 c.504C>G p.Ala168Ala exon 1 Synonymous (X:152991225 C/G).
152991227 c.506A>C p.His169Pro exon 1 Pathogenic, identified in ALD patient (145).
152991228 c.507C>T p.His169His exon 1 Synonymous (X:152991228 C/T).
152991229 c.508G>A p.Ala170Thr exon 1 VUS (X:152991229 G/A) frequency 1/178118 control alleles.
152991231 c.510delC p.Tyr171Thrfs*27 exon 1 Pathogenic, identified in ALD patient (33). Deleterious mutation.
152991232 c.511T>C p.Tyr171His exon 1 VUS (X:152991232 T/C) frequency 1/178233 control alleles.
152991233 c.512A>C p.Tyr171Ser exon 1 Pathogenic, identified in ALD patient (32).
152991235 c.514C>T p.Arg172Cys exon 1 VUS (X:152991235 C/T) frequency 1/178298 control alleles.
152991235 c.514delC p.Arg172Alafs*26 exon 1 Pathogenic, identified in ALD patient (33). Deleterious mutation.
152991236 c.515G>A p.Arg172His exon 1 VUS (X:152991236 G/A) frequency 5/200163 control alleles.
152991236 c.515_16insC p.Leu173Profs*23 exon 1 Pathogenic, identified in ALD patient (47, 166). Deleterious mutation. No detectable ALDP in patient cells (166).
152991239 c.518T>C p.Leu173Pro exon 1 Pathogenic, identified in ALD patient (52).
152991241 c.520T>C p.Tyr174His exon 1 Pathogenic, identified in ALD patient (33).
152991241 c.520T>G p.Tyr174Asp exon 1 Pathogenic, identified in 3 ALD patients (8, 15).
152991242 c.521A>G p.Tyr174Cys exon 1 Pathogenic, identified in 31 ALD patients (29, 32, 33, 47, 49, 60, 62, 88, 93, 120, 137, 182). No detectable ALDP in patient cells (32, 49, 60).
152991242 c.521A>C p.Tyr174Ser exon 1 Pathogenic, identified in 5 ALD patients (33, 60, 88, 145). Normal ALDP level in patient cells (60), but non-functional.
152991243 c.522_24del p.Phe175del exon 1 Pathogenic, identified in ALD patient (53). Reduced ALDP expression in patient cells (53).
152991245 c.524_26del p.Phe175del exon 1 Pathogenic, identified in ALD patient (32).
152991247 c.526T>A p.Ser176Thr exon 1 VUS (X:152991247 T/A) frequency 1/178394 control alleles
152991250 c.529C>A p.Gln177Lys exon 1 Pathogenic, identified in ALD patient (93).
152991250 c.529C>T p.Gln177* exon 1 Pathogenic, identified in 14 ALD patients (29, 32, 33, 49, 60, 62, 86, 88, 93, 137, 141). Deleterious mutation. No detectable ALDP expression in patient cells (32, 49, 60, 141).
152991253 c.532C>G p.Gln178Glu exon 1 Pathogenicity of the variant p.Gln178Glu is unclear. It was identified in 3 ALD patients (4, 38), but in combination with a true pathogenic mutation, p.Tyr212*.
152991253 c.[532C>G; 636C>G] p.[Gln178Glu; p.Tyr212*] exon 1 Pathogenic, identified in 3 ALD patients (4, 38).
152991253 c.532C>T p.Gln178* exon 1 Pathogenic, identified in ALD patient (125). Deleterious mutation.
152991256 c.535A>T p.Thr179Ser exon 1 VUS (X:152991256 A/T) frequency 1/178372 control alleles
152991258 c.537C>T p.Thr179Thr exon 1 Synonymous (X:152991258 C/T).
152991259 c.538T>C p.Tyr180His exon 1 VUS (X:152991259 T/C).
152991261 c.540_41insT p.Tyr181Leufs*14 exon 1 Pathogenic, identified in ALD patient (60). Deleterious mutation. No detectable ALDP expression in patient cells (60).
152991262 c.541_42del p.Tyr181Profs*13 exon 1 Pathogenic, identified in ALD patient (7). Deleterious mutation. No detectable ALDP expression in patient cells (7).
152991263 c.542A>T p.Tyr181Phe exon 1 VUS (X:152991263 A/T) frequency 1/178358 control alleles
152991263 c.542A>G p.Tyr181Cys exon 1 Pathogenic, identified in ALD 6 patients (7, 32, 49, 52, 63, 88). No detectable ALDP in patient cells (32).
152991264 c.543C>A p.Tyr181* exon 1 Pathogenic, identified in 7 ALD patients (16, 32, 146). Deleterious mutation. No detectable ALDP in patient cells (32, 146).
152991258 c.544_45insCTACTACC p.Arg182Profs*19 exon 1 Pathogenic, identified in ALD patient (49). Deleterious mutation.
152991266 c.545G>C p.Arg182Pro exon 1 Pathogenic, identified in 10 ALD patients (13, 33, 59, 64, 132, 137).
152991269 c.548T>G p.Val183Gly exon 1 Pathogenic, identified in ALD patient (33).
152991276 c.555C>A p.Asn185Lys exon 1 VUS (X:152991276 C/A) frequency 1/178299 control alleles.
152991282 c.561C>T p.Asp187Asp exon 1 Synonymous (X:152991282 C/T).
152991283 c.562G>A p.Gly188Arg exon 1 VUS (X:152991283 G/A) frequency 5/178202 control alleles.
152991284 c.563G>C p.Gly188Ala exon 1 VUS (X:152991284 G/C) frequency 1/178207 control alleles.
152991286 c.565C>T p.Arg189Trp exon 1 Pathogenic, identified in 4 ALD patients (29, 33, 60). Normal ALDP level in patient cells (60), but non-functional.
152991287 c.566G>A p.Arg189Gln exon 1 Pathogenic, identified in ALD patient (33).
152991290 c.569T>C p.Leu190Pro exon 1 Pathogenic, identified in ALD patient (38).
152991293 c.572G>A p.Arg191His exon 1 VUS (X:152991293 G/A) frequency 2/178079 control alleles.
152991298 c.577C>T p.Pro193Ser exon 1 VUS (X:152991298 C/T) frequency 1/178086 control alleles.
152991301 c.580G>A p.Asp194Asn exon 1 Pathogenic, identified in 2 ALD patients (16, 58). Affects ALDP stability in patient cells (58).
152991301 c.580G>C p.Asp194His exon 1 Pathogenic, identified in 7 ALD patients (32, 58, 97, 146). Affects ALDP stability (60% of control cells (97)) in patient cells (58, 97, 146).
152991302 c.581_89del p.Asp194_Leu197delinsVal exon 1 Pathogenic, identified in ALD patient (51).
152991303 c.582C>G p.Asp194Glu exon 1 Pathogenic, identified in ALD patient (32).
152991304 c.583C>T p.Gln195* exon 1 Pathogenic, identified in ALD patient (49). Deleterious mutation.
152991309 c.588_89delCT p.Leu197Aspfs*103 exon 1 Pathogenic, identified in 2 ALD patients (33, 105). Deleterious mutation.
152991312 c.591_92insT p.Thr198Tyrfs*103 exon 1 Pathogenic, identified in ALD patient (24). Deleterious mutation.
152991314 c.593C>A p.Thr198Lys exon 1 Pathogenic, identified in ALD patient (49).
152991314 c.593C>G p.Thr198Arg exon 1 Pathogenic, identified in ALD patient (96).
152991314 c.593C>T p.Thr198Met exon 1 Pathogenic, identified in ALD patient (33).
152991315 c.594G>A p.Thr198Thr exon 1 Synonymous (X:152991315 G/A).
152991316 c.595G>A p.Glu199Lys exon 1 Pathogenic, identified in 2 ALD patients (33, 100).
152991319 c.598G>A p.Asp200Asn exon 1 Pathogenic, identified in 2 ALD patients (24, 100).
152991319 c.598delC p.Asp200Thrfs*16 exon 1 Pathogenic, identified in ALD patient (90). Deleterious mutation.
152991320 c.599A>T p.Asp200Val exon 1 Pathogenic, identified in ALD patient (7).
152991321 c.600C>T p.Asp200Asp exon 1 Synonymous (X:152991321 C/T).
152991322 c.601G>A p.Val201Met exon 1 Benign variant based on 34/199299 control alleles (X:152991322 G/A).
152991333 c.612del p.Phe204Leufs*12 exon 1 Pathogenic, identified in ALD patient (145). Deleterious mutation.
152991335 c.614C>T p.Ala205Val exon 1 VUS (X:152991335 C/T).
152991335 c.614C>A p.Ala205Glu exon 1 Pathogenic, identified in 2 ALD patients (33).
152991335 c.614_622dup p.Ala205_Ser207dup exon 1 Pathogenic, identified in 2 ALD patients (29, 49). (Originally reported as c.622_23insCGGCCTCTG).
152991336 c.615G>A p.Ala205Ala exon 1 Synonymous (X:152991336 G/A).
152991339 c.621_900+384del664 p.Val208Trpfs*35 exon 1 Pathogenic, identified in 5 ALD patient (32, 49, 141). Deleterious mutation. No detectable ALDP expression in patient cells (32, 49, 141).
152991340 c.619_27del p.Ser207_Ala209del exon 1 Pathogenic, identified in ALD patient (62). No detectable ALDP expression in patient cells (62).
152991343 c.622_634del p.Val208Thrfs*4 exon 1 Pathogenic, identified in ALD patient (15). Deleterious mutation. (Originally reported as c.618_30del).
152991343 c.622dupG p.Val208Glyfs*93 exon 1 Pathogenic, identified in ALD patient (86). Deleterious mutation.
152991344 c.623T>A p.Val208Glu exon 1 Pathogenic, identified in 2 ALD patients (158).
152991353 c.632T>C p.Leu211Pro exon 1 Pathogenic, identified in 2 ALD patients (15, 177).
152991354 c.633C>A p.Leu211Leu exon 1 Synonymous (X:152991354 C/A).
152991357 c.636C>G p.Tyr212* exon 1 Pathogenic, identified in 4 ALD patients (4, 38, 38, 158). Deleterious mutation.
152991359 c.638C>G p.Ser213Cys exon 1 Pathogenic, identified in 2 ALD patients (27, 158).
152991359 c.638C>T p.Ser213Phe exon 1 Pathogenic, identified in ALD patient (32).
152991361 c.640A>G p.Asn214Asp exon 1 Pathogenic, identified in 2 ALD patients (24, 90).
152991364 c.643del p.Leu215* exon 1 Pathogenic, identified in 5 ALD patients (32, 141). Deleterious mutation. No detectable ALDP expression in patient cells (32, 141).
152991370 c.649A>G p.Lys217Glu exon 1 Pathogenic, identified in 6 ALD patients (32, 48, 49, 93, 167). Normal ALDP level in patient cells (49), but non-functional (48).
152991370 c.649A>T p.Lys217* exon 1 Pathogenic, identified in ALD patient (88). Deleterious mutation.
152991373 c.652C>A p.Pro218Thr exon 1 Pathogenic, identified in 6 ALD patients (29, 32, 49, 145). Normal ALDP level in patient cells (32), but non-functional (32).
152991373 c.[652C>T; 664G>T] p.[Pro218Ser; Val222Leu] exon 1 Pathogenic, identified in 3 ALD patients (98). Unclear which of the variants is pathogenic.
152991374 c.653C>G p.Pro218Arg exon 1 Pathogenic, identified in 3 ALD patients (175).
152991380 c.659T>C p.Leu220Pro exon 1 Pathogenic, identified in 28 ALD patients (16, 32, 97, 141, 146). Reduced (22% of control cells) ALDP in patient cells (32, 97, 141, 146).
152991381 c.660G>A p.Leu220Leu exon 1 Synonymous (X:152991381 G/A).
152991381 c.660G>T p.Leu220Leu exon 1 Synonymous (X:152991381 G/T).
152991383 c.662_702del p.Asp221Valfs*66 exon 1 Pathogenic, identified in ALD patient (33). Deleterious mutation.
152991383 c.662A>G p.Asp221Gly exon 1 Pathogenic, identified in 3 ALD patients (7, 33). No detectable ALDP expression in patient cells (7).
152991385 c.[664G>T;652C>T] p.[Val222Leu;Pro218Ser] exon 1 Pathogenic, identified in 3 ALD patients (98). Unclear which of the variants is pathogenic.
152991385 c.664G>A p.Val222Met exon 1 VUS (X:152991385 G/A) frequency 3/176462 control alleles.
152991385 c.664_70dup p.Val224Glyfs*79 exon 1 Pathogenic, identified in ALD patient (58). Deleterious mutation.
152991388 c.667G>C p.Ala223Pro exon 1 VUS (X:152991388 G/C) frequency 2/198242 control alleles.
152991389 c.668C>T p.Ala223Val exon 1 VUS (X:152991389 C/T) frequency 2/176342 control alleles.
152991389 c.668C>A p.Ala223Asp exon 1 Pathogenic, identified in 2 ALD patients (33, 113).
152991392 c.671T>G p.Val224Gly exon 1 Pathogenic, identified in 2 ALD patients (33, 49).
152991394 c.673A>G p.Thr225Ala exon 1 VUS (X:152991394 A/G) frequency 1/176356 control alleles
152991395 c.674C>T p.Thr225Ile exon 1 VUS (X:152991395 C/T) frequency 1/176348 control alleles.
152991398 c.677del p.Tyr227Thrfs*109 exon 1 Pathogenic, identified in 3 ALD patients (29, 33). Deleterious mutation.
152991400 c.679T>C p.Tyr227His exon 1 VUS (X:152991400 T/C) frequency 2/176195 control alleles.
152991402 c.681C>G p.Tyr227* exon 1 Pathogenic, identified in ALD patient (58). Deleterious mutation.
152991404 c.683C>A p.Thr228Asn exon 1 VUS (X:152991404 C/A) frequency 1/176079 control alleles
152991405 c.684_85insTACAC p.Leu229Tyrfs*109 exon 1 Pathogenic, identified in ALD patient (33). Deleterious mutation.
152991407 c.686T>C p.Leu229Pro exon 1 Pathogenic, identified in 8 ALD patients (29, 33, 47, 49, 145).
152991412 c.691C>T p.Arg231Trp exon 1 Benign, based on its frequency of 65/197483 control alleles (X:152991412 C/T).
152991413 c.692G>A p.Arg231Gln exon 1 VUS (X:152991413 G/A) frequency 2/175656 control alleles.
152991413 c.692_94delinsC p.Arg231Profs*69 exon 1 Pathogenic, identified in ALD patient (172). Deleterious mutation.
152991414 c.693_94del p.Ala232Glyfs*68 exon 1 Pathogenic, identified in 2 ALD patients (3, 33). Deleterious mutation. No detectable ALDP expression in patient cells (33).
152991416 c.695_696del p.Ala232Glyfs*68 exon 1 Pathogenic, identified in ALD patient (58). Deleterious mutation. No detectable ALDP expression in patient cells (58).
152991416 c.695_96insG p.Ala233Glyfs*68 exon 1 Pathogenic, identified in ALD patient (96). Deleterious mutation.
152991417 c.696_706del11 p.Ala233Trpfs*64 exon 1 Pathogenic, identified in ALD patient (100). Deleterious mutation.
152991417 c.696G>T p.Ala232Ala exon 1 Synonymous (X:152991417 G/T) frequency 1/175446 control alleles.
152991417 c.696G>A p.Ala232Ala exon 1 Synonymous (X:152991417 G/A) frequency 1/175276 control alleles.
152991418 c.697_900+25del p.Ala233Glyfs*100 exon 1 Pathogenic, identified in ALD patient (48). Deleterious mutation.
152991422 c.701G>A p.Arg234His exon 1 VUS (X:152991422 G/A) frequency 5/197276 control alleles.
152991427 c.706C>T p.Arg236Cys exon 1 Pathogenicity of the variant p.Arg236Cys is unclear (X:152991427 C/T) frequency 2/175366 control alleles). It was also identified in an ALD patient (33), but in combination with a true pathogenic mutation, p.Lys16*
152991427 c.706_09del p.Arg236Glufs*99 exon 1 Pathogenic, identified in ALD patient (49). Deleterious mutation.
152991428 c.707G>A p.Arg236His exon 1 Benign, based on its frequency of 253/197189 control alleles (X:152991428 G/A).
152991431 c.710G>T p.Gly237Val exon 1 VUS (X:152991431 G/T).
152991433 c.712G>A p.Ala238Thr exon 1 VUS (X:152991433 G/A).
152991435 c.714C>T p.Ala238Ala exon 1 Synonymous (X:152991435 C/T).
152991436 c.715G>A p.Gly239Ser exon 1 VUS (X:152991436 G/A) frequency 1/175039 control alleles.
152991445 c.724_28del p.Trp242Leufs*57 exon 1 Pathogenic, identified in ALD patient (3). Deleterious mutation.
152991446 c.725G>A p.Trp242* exon 1 Pathogenic, identified in ALD patient (96). Deleterious mutation.
152991447 c.726G>A p.Trp242* exon 1 Pathogenic, identified in 6 ALD patients (15, 33, 49, 59, 64, 132). Deleterious mutation. No detectable ALDP in patient cells (49).
152991451 c.730delT p.Ser244Argfs*92 exon 1 Pathogenic, identified in ALD patient (33). Deleterious mutation.
152991451 c.730_31delinsGAGA p.Ser244Glufs*93 exon 1 Pathogenic, identified in 4 ALD patients (37). Deleterious mutation.
152991452 c.731C>T p.Ser244Leu exon 1 VUS (X:152991452 C/T) frequency 2/173152 control alleles.
152991453 c.732G>A p.Ser244Ser exon 1 Synonymous (X:152991453 G/A).
152991455 c.734C>A p.Ala245Asp exon 1 Pathogenic, identified in ALD patient (32, 141). Normal ALDP level in patient cells (32, 141), but non-functional (32, 141).
152991456 c.735C>T p.Ala245Ala exon 1 Synonymous (X:152991456 C/T).
152991460 c.739G>A p.Ala247Thr exon 1 VUS (X:152991460 G/A).
152991460 c.739delG p.Ala247Profs*89 exon 1 Pathogenic, identified in ALD patient (52). Deleterious mutation.
152991460 c.739_40insGCCATCG p.Ala247Glyfs*56 exon 1 Pathogenic, identified in ALD patient (93). Deleterious mutation.
152991463 c.742G>A p.Gly248Ser exon 1 VUS (X:152991463 G/A) frequency 7/194293 control alleles.
152991463 c.742_45del p.Gly248Serfs*87 exon 1 Pathogenic, identified in ALD patient (33). Deleterious mutation.
152991469 c.748_59del p.Val250_Leu253del exon 1 Pathogenic, identified in ALD patient (33).
152991470 c.749_51del p.Val251del exon 1 Pathogenic, identified in ALD patient (33).
152991471 c.750G>A p.Val250Val exon 1 Synonymous (X:152991471 G/A).
152991478 c.757C>G p.Leu253Val exon 1 Benign, based on its frequency of 15/191124 control alleles (X:152991478 C/G).
152991478 c.757_65delinsGAGG p.Leu253Glufs*46 exon 1 Pathogenic, identified in ALD patient (60). Deleterious mutation.
152991482 c.760A>G p.Thr254Ala exon 1 Pathogenic, identified in ALD patient (33, 58). Normal ALDP level in patient cells (58), but non-functional (58).
152991481 c.760A>C p.Thr254Pro exon 1 Pathogenic, identified in 3 ALD patients (33, 90).
152991481 c.761delC p.Thr254Argfs*82 exon 1 Pathogenic, identified in 2 ALD patients (81, 104). Deleterious mutation.
152991482 c.761C>A p.Thr254Lys exon 1 Pathogenic, identified in 2 ALD patients (33, 52).
152991482 c.761C>T p.Thr254Met exon 1 Pathogenic, identified in 6 ALD patients (15, 33, 105).
152991484 c.763G>A p.Ala255Thr exon 1 VUS (X:152991484 G/A).
152991489 c.768C>T p.Asn256Asn exon 1 Synonymous (X:152991489 C/T).
152991490 c.769G>A p.Val257Met exon 1 VUS (X:152991490 G/A) frequency 1/163453 control alleles
152991494 c.773T>C p.Leu258Pro exon 1 Pathogenic, identified in ALD patient (33).
152991496 c.775C>T p.Arg259Trp exon 1 Pathogenicity of the variant p.Arg259Trp is unclear (X:152991496 C/T) frequency 2/157411 individuals. It was identified in an ALD patient (167), but in combination with a true pathogenic mutation, p.Ser108*.
152991497 c.776G>A p.Arg259Gln exon 1 VUS (X:152991497 G/A).
152991499 c.778G>A p.Ala260Thr exon 1 VUS (X:152991499 G/A) frequency 1/156948 control alleles
152991505 c.784_785del p.Ser262Alafs*38 exon 1 Pathogenic, identified in ALD patient (33). Deleterious mutation.
152991506 c.785_91del p.Ser262Cysfs*72 exon 1 Pathogenic, identified in 4 ALD patients (16). Deleterious mutation.
152991506 c.785C>A p.Ser262* exon 1 Pathogenic, identified in ALD patient (120). Deleterious mutation.
152991506 c.785C>G p.Ser262Trp exon 1 Pathogenic, identified in ALD patient (32).
152991508 c.787C>T p.Pro263Ser exon 1 Pathogenic, identified in ALD patient (33).
152991509 c.788C>T p.Pro263Leu exon 1 Pathogenic, identified in ALD patient (7). Affects ALDP stability in patient cells (7).
152991511 c.790A>T p.Lys264* exon 1 Pathogenic, identified in ALD patient (33). Deleterious mutation.
152991511 c.790A>C p.Lys264Gln exon 1 VUS (X:152991511 A/C) frequency 1/21836 control alleles
152991517 c.796G>A p.Gly266Arg exon 1 Pathogenic, identified in 33 ALD patients (8, 16, 24, 33, 49, 52, 53, 59, 62, 64, 67, 72, 88, 90, 93, 96, 105, 132, 137, 162). Normal ALDP level in patient cells (53, 72), but non-functional.
152991517 c.796G>C p.Gly266Arg exon 1 Pathogenic, identified in ALD patient (58). Normal ALDP level in patient cells (58), but non-functional.
152991518 c.797G>A p.Gly266Glu exon 1 Pathogenic, identified in 3 ALD patients (49, 96).
152991520 c.799G>A p.Glu267Lys exon 1 Pathogenic, identified in ALD patient (51).
152991520 c.799G>T p.Glu267* exon 1 Pathogenic, identified in ALD patient (33). Deleterious mutation.
152991520 c.799del p.Glu267Serfs*69 exon 1 Pathogenic, identified in ALD patient (15). Deleterious mutation.
152991530 c.809C>T p.Ala270Val exon 1 VUS (X:152991530 C/T) frequency 5/165970 control alleles.
152991532 c.811G>A p.Glu271Lys exon 1 Pathogenic, identified in ALD patient (24).
152991536 c.815_17del p.Glu272del exon 1 Pathogenic, identified in ALD patient (33).
152991539 c.818C>A p.Ala273Glu exon 1 Pathogenic, identified in ALD patient (58). Normal ALDP level in patient cells (58), but non-functional.
152991540 c.819G>A p.Ala273Ala exon 1 Synonymous (X:152991540 G/A).
152991541 c.820C>T p.Arg274Trp exon 1 VUS (X:152991541 C/T). Identified in 2/31066 control alleles.
152991541 c.[820C>T; 838C>T] p.[Arg274Trp; Arg280Cys] exon 1 Pathogenic, identified in ALD patient (49). p.Arg274Trp is most likely benign and p.Arg280Cys is pathogenic.
152991542 c.821G>A p.Arg274Gln exon 1 VUS (X:152991542 G/A) frequency 1/21809 control alleles.
152991544 c.823C>T p.Arg275Trp exon 1 Pathogenic, identified in 8 ALD patients (extended family screening) (181).
152991547 c.826A>G p.Lys276Glu exon 1 Pathogenic, identified in 2 ALD patients (22, 86). Normal ALDP level in patient cells (22), but non-functional.
152991549 c.828_29insAAT p.Gly277_Glu278insAsn exon 1 Pathogenic, identified in 2 ALD patients (15, 158).
152991550 c.829G>A p.Gly277Arg exon 1 Pathogenic, identified in 5 ALD patients (15, 33, 60, 88). Normal ALDP level in patient cells (60), but non-functional.
152991550 c.829G>C p.Gly277Arg exon 1 Pathogenic, identified in 4 ALD patients (27, 60). Normal ALDP level in patient cells (60), but non-functional.
152991550 c.829G>T p.Gly277Trp exon 1 Pathogenic, identified in 2 ALD patients (13, 27).
152991551 c.830G>A p.Gly277Glu exon 1 Pathogenic, identified in ALD patient (33).
152991553 c.832G>A p.Glu278Lys exon 1 VUS (X:152991553 G/A).
152991553 c.832G>T p.Glu278* exon 1 Pathogenic, identified in 3 ALD patients (32, 58). Deleterious mutation. No detectable ALDP expression in patient cells (58).
152991553 c.832_34delinsAC p.Glu278Thrfs*58 exon 1 Pathogenic, identified in ALD patient (58). Deleterious mutation.
152991557 c.836T>C p.Leu279Pro exon 1 Pathogenic, identified in ALD patient (60). No detectable ALDP expression in patient cells (60).
152991558 c.837G>A p.Leu279Leu exon 1 Synonymous (X:152991558 G/A).
152991559 c.838C>A p.Arg280Ser exon 1 VUS (X:152991559 C/A).
152991559 c.838C>T p.Arg280Cys exon 1 Pathogenic, identified in 9 ALD patients (32, 33, 50, 60). Normal ALDP level in patient cells (60), but non-functional.
152991560 c.839G>T p.Arg280Leu exon 1 Pathogenic, identified in 2 ALD patients (55, 93).
152991568 c.847C>T p.His283Tyr exon 1 Pathogenic, identified in 5 ALD patients (32, 141). Affects ALDP stability in patient cells (32, 141).
152991568 c.847C>G p.His283Asp exon 1 Pathogenic, identified in 5 ALD patients (59, 64, 93, 132, 137).
152991569 c.848A>G p.His283Arg exon 1 Pathogenic, identified in 7 ALD patients (89, 93, 173).
152991572 c.851C>A p.Ser284* exon 1 Pathogenic, identified in ALD patient (32). Deleterious mutation. No detectable ALDP expression in patient cells (32).
152991573 c.852_53insACTC p.Arg285Thrfs*17 exon 1 Pathogenic, identified in 2 ALD patients (33, 104). Deleterious mutation.
152991573 c.852dup p.Arg285Alafs*16 exon 1 Pathogenic, identified in ALD patient (33). Deleterious mutation.
152991574 c.853C>G p.Arg285Gly exon 1 Pathogenic, identified in ALD patient (145).
152991575 c.854G>C p.Arg285Pro exon 1 Pathogenic, identified in 2 ALD patients (27, 49).
152991575 c.854G>A p.Arg285His exon 1 VUS (X:152991575 G/A) frequency 1/21761 control alleles
152991580 c.859G>T p.Val287Leu exon 1 VUS (X:152991580 G/T).
152991590 c.869del p.Ser290Trpfs*46 exon 1 Pathogenic, identified in ALD patient (58). Deleterious mutation.
152991590 c.869C>G p.Ser290Trp exon 1 Pathogenic, identified in ALD patient (90).
152991590 c.869C>A p.Ser290* exon 1 Pathogenic, identified in ALD patient (49). Deleterious mutation. No detectable ALDP expression in patient cells (49).
152991592 c.871G>A p.Glu291Lys exon 1 Pathogenic, identified in 7 ALD patients (5, 58, 59, 60, 64, 132, 137). No detectable ALDP expression in patient cells (58, 60).
152991593 c.872A>G p.Glu291Gly exon 1 Pathogenic, identified in 3 ALD patients (145).
152991594 c.873G>C p.Glu291Asp exon 1 Pathogenic, identified in 2 ALD patients (22, 33). No detectable ALDP expression in patient cells (22, 33).
152991595 c.874_76delGAG p.Glu292del exon 1 Pathogenic, identified in 22 ALD patients (15, 22, 24, 31, 32, 33, 49, 178). No detectable ALDP expression in patient cells (22, 32, 33, 49). (Also reported as p.Glu291del).
152991595 c.874G>A p.Glu292Lys exon 1 Pathogenic, identified in 2 ALD patients (184).
152991601 c.880G>A p.Ala294Thr exon 1 Pathogenic, identified in ALD patient (7, 32).
152991602 c.881C>T p.Arg294Val exon 1 Pathogenic, identified in ALD patient (33).
152991603 c.882_883insGC p.Phe295Alafs*42 exon 1 Pathogenic, identified in ALD patient (58). Deleterious mutation.
152991606 c.885delinsTA p.Tyr296Ilefs*5 exon 1 Pathogenic, identified in ALD patient (33). Deleterious mutation.
152991607 c.886_99del14 p.Tyr296Glyfs*100 exon 1 Pathogenic, identified in ALD patient (27). Deleterious mutation.
152991607 c.886T>C p.Tyr296His exon 1 Pathogenic, identified in ALD patient (33).
152991608 c.887A>G p.Tyr296Cys exon 1 Pathogenic, identified in 26 ALD patients (24, 33, 49, 52, 59, 62, 64, 88, 100, 115, 125, 132, 137). Normal ALDP level in patient cells (58), but non-functional.
152991608 c.887A>C p.Tyr296Ser exon 1 Pathogenic, identified in ALD patient (33).
152991609 c.888T>G p.Tyr296* exon 1 Pathogenic, identified in ALD patient (58). Deleterious mutation. No detectable ALDP expression in patient cells (58).
152991613 c.892G>C p.Gly298Arg exon 1 Pathogenic, identified in ALD patient (125).
152991613 c.892G>A p.Gly298Ser exon 1 Pathogenic, identified in 5 ALD patients (32, 33).
152991613 c.892_96delinsGTCA p.Gly298Valfs*38 exon 1 Pathogenic, identified in ALD patient (58). Deleterious mutation. No detectable ALDP expression in patient cells (58).
152991613 c.892_93insGC p.His299Profs*38 exon 1 Pathogenic, identified in ALD patient (58). Deleterious mutation.
152991614 c.893G>A p.Gly298Asp exon 1 Pathogenic, identified in ALD patient (29, 38, 58, 125). No detectable ALDP expression in patient cells (58).
152991614 c.893G>T p.Gly298Val exon 1 Pathogenic, identified in ALD patient (33).
152991614 c.893_94delinsT p.Gly298Valfs*38 exon 1 Pathogenic, identified in ALD patient (53, 84). Deleterious mutation. No detectable ALDP expression in patient cells (53).
152991614 c.893_894insG p.His299Alafs*2 exon 1 Pathogenic, identified in ALD patient (33). Deleterious mutation.
152991616 c.895C>T p.His299Tyr exon 1 Benign, based on frequency (23/112915 control alleles (X:152991616 C/T).
152991617 c.896A>G p.His299Arg exon 1 Pathogenic, identified in ALD patient (32).
152991621 c.900G>A p.Val301fs*34 exon 1 Pathogenic, identified in 3 ALD patients (33, 53, 152). Reduced (7% of control cells) ALDP in patient cells due to splicing defect (152).
152991622 c.900+1G>T p.Val301fs*? IVS 1 Pathogenic, identified in 4 ALD patients (49, 59, 64, 132). Deleterious mutation.
152991622 c.900+1G>A p.Val301fs*? IVS 1 Pathogenic, identified in 3 ALD patients (33, 100, 117). Deleterious mutation.
152991623 c.900+2T>C p.Val301fs*? IVS 1 Pathogenic, identified in ALD patient (33). Deleterious mutation.
152991633 c.900+12T>A IVS 1 VUS (X:152991633 T/A).
152991648 c.900+27G>A IVS 1 VUS (X:152991648 G/A) frequency 9/88236 control alleles.
152991651 c.900+30G>A IVS 1 VUS (X:152991651 G/A) frequency 10/87692 control alleles.
152994671 c.901-16C>T IVS 1 Benign, based on its frequency of 1567/199361 control alleles (X:152994671 C/T).
152994677 c.901-10C>T IVS 1 Benign, based on its frequency of 720/199300 control alleles (X:152994677 C/T).
152994678 c.901-9C>A IVS 1 VUS (X:152994678 C/A)
152994682 c.901-5C>T IVS 1 VUS (X:152994682 C/T).
152994683 c.901-4G>A IVS 1 VUS (X:152994683 G/A).
152994684 c.901-3C>G p.Val301fs*? IVS 1 Pathogenic, identified in ALD patient (60). No detectable ALDP in patient cells (60).
152994685 c.901-2A>C p.Val301fs*? IVS 1 Pathogenic, identified in ALD patient (68). Deleterious mutation.
152994686 c.901-1G>A p.Val301fs*? IVS 1 Pathogenic, identified in 6 ALD patients (33, 49, 62, 111, 125). Deleterious mutation.
152994690 c.904G>A p.Glu302Lys exon 2 Pathogenic, identified in 4 ALD patients (21, 58, 72). Affects ALDP stability in patient cells (58, 72).
152994690 c.904G>C p.Glu302Gln exon 2 Pathogenic, identified in ALD patient (32).Affects ALDP stability in patient cells (32).
152994691 c.905A>T p.Glu302Val exon 2 Pathogenic, identified in ALD patient (88).
152994691 c.905A>G p.Glu302Gly exon 2 Pathogenic, identified in ALD patient (33).
152994692 c.906G>A p.Glu302Glu exon 2 Synonymous (X:152994692 G/A).
152994692 c.906G>C p.Glu302Asp exon 2 Pathogenic, identified in ALD patient (137).
152994696 c.910G>A p.Ala304Thr exon 2 VUS (X:152994696 G/A) frequency 1/178349 control alleles
152994696 c.910del p.Ala304Profs*32 exon 2 Pathogenic, identified in ALD patient (84). Deleterious mutation.
152994699 c.913C>T p.Leu305Leu exon 2 VUS (X:152994699 C/T) frequency 2/178390 control alleles
152994705 c.919C>T p.Gln307* exon 2 Pathogenic, identified in 5 ALD patients (62, 63, 127). Deleterious mutation.
152994707 c.921G>A p.Gln307Gln exon 2 Synonymous (X:152994707 G/A).
152994708 c.922C>T p.Arg308Cys exon 2 VUS (X:152994708 C/T) frequency 4/200081 control alleles.
152994709 c.923G>A p.Arg308His exon 2 VUS (X:152994709 G/A) frequency 5/178473 control alleles.
152994717 c.931C>T p.Gln311* exon 2 Pathogenic, identified in 4 ALD patients (2, 60). Deleterious mutation. No detectable ALDP in patient cells (60).
152994718 c.932dup p.Asp312Glyfs*89 exon 2 Pathogenic, identified in ALD patient (58). Deleterious mutation.
152994719 c.933_34insA p.Asp312Argfs*89 exon 2 Pathogenic, identified in ALD patient (58). Deleterious mutation. No detectable ALDP in patient cells (58).
152994721 c.935del p.Asp312Alafs*24 exon 2 Pathogenic, identified in 2 ALD patient (35). Deleterious mutation.
152994722 c.936C>G p.Asp312Glu exon 2 VUS (X:152994722 C/G).
152994723 c.937delC p.Leu313Trpfs*23 exon 2 Pathogenic, identified in ALD patient (59, 64). Deleterious mutation.
152994724 c.938T>C p.Leu313Pro exon 2 Pathogenic, identified in 3 ALD patients (33, 88, 90).
152994726 c.940G>C p.Ala314Pro exon 2 Pathogenic, identified in ALD patient (93).
152994729 c.943del p.Ser315Argfs*21 exon 2 Pathogenic, identified in ALD patient (58). Deleterious mutation. No detectable ALDP in patient cells (58).
152994730 c.944C>T p.Ser315Leu exon 2 VUS (X:152994730 C/T) frequency 2/178647 control alleles.
152994730 c.944C>A p.Ser315* exon 2 Pathogenic, identified in ALD patient (49). Deleterious mutation.
152994731 c.945G>A p.Ser315Ser exon 2 Synonymous (X:152994731 G/A).
152994733 c.947A>C p.Gln316Pro exon 2 Pathogenic, identified in 2 ALD patients (129).
152994739 c.953A>G p.Asn318Ser exon 2 VUS (X:152994739 A/G) frequency 1/178710 control alleles
152994750 c.964C>A p.Leu322Met exon 2 VUS (X:152994750 C/A) frequency 1/178734 control alleles.
152994751 c.965T>C p.Leu322Pro exon 2 Pathogenic, identified in 4 ALD patients (26, 33, 62, 135).
152994754 c.968A>T p.Glu323Val exon 2 VUS (X:152994754 A/T) frequency 1/178740 control alleles.
152994757 c.971G>A p.Arg324His exon 2 VUS (X:152994757 G/A).
152994760 c.974T>C p.Leu325Pro exon 2 Pathogenic, identified in 3 ALD patients (33, 125).
152994763 c.977G>A p.Trp326* exon 2 Pathogenic, identified in 3 ALD patients (2, 60, 154). Deleterious mutation.
152994764 c.978G>A p.Trp326* exon 2 Pathogenic, identified in ALD patient (100). Deleterious mutation.
152994765 c.979_80insT p.Tyr327Leufs*74 exon 2 Pathogenic, identified in ALD patient (60). Deleterious mutation. No detectable ALDP expression in patient cells (60).
152994767 c.981T>A p.Tyr327* exon 2 Pathogenic, identified in ALD patient (38). Deleterious mutation.
152994768 c.982G>T p.Val328Phe exon 2 Pathogenic, identified in ALD patient (120).
152994771 c.985A>C p.Met329Leu exon 2 VUS (X:152994771 A/C) frequency 1/178746 control alleles
152994772 c.986T>C p.Met329Thr exon 2 VUS (X:152994772 T/C) frequency 2/178750 control alleles
152994772 c.986T>G p.Met329Arg exon 2 Pathogenic, identified in ALD patient (33).
152994774 c.988_1005del p.Leu330_Met335del exon 2 Pathogenic, identified in ALD patient (33).
152994777 c.991G>A p.Glu331Lys exon 2 Pathogenic, identified in ALD patient (33).
152994777 c.991G>T p.Glu331* exon 2 Pathogenic, identified in ALD patient (58). Deleterious mutation.
152994780 c.994C>T p.Gln332* exon 2 Pathogenic, identified in 2 ALD patients (63, 165). Deleterious mutation. No detectable ALDP expression in patient cells (63).
152994787 c.1001T>C p.Leu334Pro exon 2 Pathogenic, identified in ALD patient (33).
152994790 c.1004T>G p.Met335Arg exon 2 Pathogenic, identified in ALD patient (33).
152994793 c.1007A>T p.Lys336Met exon 2 Pathogenic, identified in ALD patient (49).
152994794 c.1008G>T p.Lys336Asn exon 2 Pathogenic, identified in ALD patient (32).
152994794 c.1008G>C p.Lys336Asn exon 2 Pathogenic, identified in ALD patient (145).
152994795 c.1009T>C p.Tyr337His exon 2 Pathogenic, identified in ALD patient (33).
152994797 c.1011T>A p.Tyr337* exon 2 Pathogenic, identified in ALD patient (33). Deleterious mutation.
152994800 c.1014G>A p.Val338Val exon 2 Synonymous (X:152994800 G/A).
152994801 c.1015T>C p.Trp339Arg exon 2 Pathogenic, identified in ALD patient (38).
152994801 c.1015T>G p.Trp339Gly exon 2 Pathogenic, identified in 2 ALD patients (186).
152994802 c.1016G>C p.Trp339Ser exon 2 Pathogenic, identified in ALD patient (145).
152994802 c.1016G>A p.Trp339* exon 2 Pathogenic, identified in ALD patient (33). Deleterious mutation.
152994803 c.1017G>A p.Trp339* exon 2 Pathogenic, identified in 2 ALD patients (33). Deleterious mutation.
152994803 c.1017G>T p.Trp339Cys exon 2 Pathogenic, identified in ALD patient (125).
152994806 c.1020C>T p.Ser340Ser exon 2 Synonymous (X:152994806 C/T).
152994807 c.1021G>A p.Ala341Thr exon 2 VUS (X:152994807 G/A) frequency 1/178613 control alleles.
152994807 c.1021G>T p.Ala341Ser exon 2 VUS (X:152994807 G/T) frequency 9/178613 control alleles.
152994808 c.1022C>A p.Ala341Asp exon 2 Pathogenic, identified in ALD patient (104). Confirmed by functional studies (104).
152994810 c.1024T>C p.Ser342Pro exon 2 Pathogenic, identified in 3 ALD patients (22, 33). Normal ALDP level in patient cells (22, 33), but non-functional (22, 33).
152994813 c.1027G>A p.Gly343Ser exon 2 Pathogenic, identified in 2 ALD patients (63, 165).
152994814 c.1028G>A p.Gly343Asp exon 2 Pathogenic, identified in 2 ALD patients (33, 49).
152994814 c.1028G>T p.Gly343Val exon 2 Pathogenic, identified in 12 ALD patients (59, 64, 93, 108, 132, 137, 145, 174).
152994817 c.1031T>C p.Leu344Pro exon 2 Pathogenic, identified in ALD patient (33).
152994833 c.1047C>A p.Val349Val exon 2 Synonymous (X:152994833 C/A).
152994836 c.1050del p.Ile351Serfs*15 exon 2 Pathogenic, identified in ALD patient (32). Deleterious mutation.
152994854 c.1068C>T p.Gly356Gly exon 2 Synonymous (X:152994854 C/T).
152994855 c.1069_70delTinsGCC p.Tyr357Alafs*10 exon 2 Pathogenic, identified in 2 ALD patients (38). Deleterious mutation.
152994858 c.1072T>C p.Ser358Pro exon 2 Benign variant (X:152994858 T/C) frequency 3/177946 control alleles, confirmed by biochemical testing (139).
152994859 c.1073C>G p.Ser358* exon 2 Pathogenic, identified in 3 ALD patients (60, 100, 154). Deleterious mutation. No detectable ALDP expression in patient cells (60).
152994860 c.1074_75insA p.Glu359Argfs*42 exon 2 Pathogenic, identified in ALD patient (100). Deleterious mutation.
152994862 c.1076_77delAG p.Glu359Argfs*41 exon 2 Pathogenic, identified in 2 ALD patients (37, 145). Deleterious mutation.
152994865 c.1079C>G p.Ser360* exon 2 Pathogenic, identified in 2 ALD patients (33). Deleterious mutation.
152994868 c.1081+1G>T p.Asp361fs*? IVS 2 Pathogenic, identified in 2 ALD patients (32). Deleterious mutation.
152994872 c.1081+5G>T p.Asp361fs*? IVS 2 Pathogenic, identified in 2 ALD patients (32, 104). Deleterious mutation. No detectable ALDP expression in patient cells (104).
152994875 c.1081+8C>T IVS 2 VUS (X:152994875 C/T)
153001534 c.1082-32>delC IVS 2 Benign, based on its frequency of 81/190710 control alleles (X:153001534 GC/G)
153001535 c.1082-31C>T IVS 2 VUS (X:153001535 C/T)
153001539 c.1082-27G>A IVS 2 VUS (X:153001539 G/A)
153001546 c.1082-20A>G IVS 2 VUS (X:153001546 A/G)
153001547 c.1082-19C>G IVS 2 Benign, based on its frequency of 84/197384 control alleles (X:153001547 C/G)
153001551 c.1082-15T>C IVS 2 VUS (X:153001551 T/C).
153001566 c.1082A>G p.Asp361Gly exon 3 VUS (X:153001566 A/G) frequency 3/177457 control alleles.
153001567 c.1083T>A p.Asp361Glu exon 3 VUS (X:153001567 T/A) frequency 1/177463 control alleles.
153001567 c.1083T>C p.Asp361Asp exon 3 Synonymous (X:153001567 T/C).
153001568 c.1084G>A p.Ala362Thr exon 3 VUS (X:153001568 G/A) frequency 1/177465 control alleles
153001574 c.1090del p.Ala364Profs*2 exon 3 Pathogenic, identified in ALD patient (33). Deleterious mutation.
153001576 c.1092del p.Ala365* exon 3 Pathogenic, identified in ALD patient (48). Deleterious mutation.
153001576 c.1092_93insA p.Val365Serfs*36 exon 3 Pathogenic, identified in ALD patient (33). Deleterious mutation.
153001576 c.1092C>T p.Ala364Ala exon 3 Synonymous (X:153001576 C/T).
153001577 c.1093G>A p.Val365Met exon 3 VUS (X:153001577 G/A) frequency 5/177817 controle alleles..
153001577 c.1093G>C p.Val365Leu exon 3 VUS (X:153001577 G/C) frequency 1/177817 control alleles
153001578 c.1094T>A p.Val365Glu exon 3 VUS (X:153001578 T/A) frequency 1/177881 control alleles
153001580 c.1096A>T p.Lys366* exon 3 Pathogenic, identified in 3 ALD patients (181). Deleterious mutation.
153001581 c.1097A>G p.Lys366Arg exon 3 VUS (X:153001581 A/G) frequency 1/178004 control alleles
153001593 c.1109T>A p.Leu370* exon 3 Pathogenic, identified in 3 ALD patients (120). Deleterious mutation.
153001597 c.1113A>C p.Glu371Asp exon 3 VUS (X:153001597 A/C) frequency 1/178342 control alleles
153001598 c.1114A>T p.Lys372* exon 3 Pathogenic, identified in ALD patient (33). Deleterious mutation.
153001601 c.1117A>G p.Lys373Glu exon 3 VUS (X:153001601 A/G) frequency 21/200035 control alleles.
153001601 c.1117_19del p.Lys373del exon 3 Pathogenic, identified in ALD patient (33).
153001603 c.1119G>C p.Lys373Asn exon 3 VUS (X:153001603 G/C) frequency 1/178411 control alleles.
153001604 c.1120G>A p.Glu374Lys exon 3 VUS (X:153001604 G/A) frequency 2/178403 control alleles.
153001609 c.1125G>A p.Glu375Glu exon 3 Synonymous (X:153001609 G/A).
153001610 c.1126G>C p.Glu376Gln exon 3 VUS (X:153001610 G/C) frequency 6/200118 control alleles.
153001618 c.1134G>A p.Val378Val exon 3 Synonymous (X:153001618 G/A).
153001619 c.1135_36insC p.Ser379Thrfs*22 exon 3 Pathogenic, identified in ALD patient (7). Deleterious mutation. No detectable ALDP expression in patient cells (7).
153001621 c.1137dup p.Glu380Argfs*21 exon 3 Pathogenic, identified in ALD patient (104). Deleterious mutation.
153001621 c.1137C>G p.Ser379Arg exon 3 Pathogenic, identified in ALD patient (33).
153001622 c.1138G>A p.Glu380Lys exon 3 VUS (X:153001622 G/A) frequency 1/178506 control alleles.
153001625 c.1141C>T p.Arg381Cys exon 3 VUS (X:153001625 C/T) frequency 5/200035 control alleles.
153001626 c.1142G>A p.Arg381His exon 3 VUS (X:153001626 G/A) frequency 6/200072 control alleles.
153001634 c.1150G>A p.Ala384Thr exon 3 VUS (X:153001634 G/A) frequency 1/178617 control alleles.
153001635 c.1151C>G p.Ala384Gly exon 3 VUS (X:153001635 C/G) frequency 2/178634 control alleles.
153001636 c.1152C>T p.Ala384Ala exon 3 Synonymous (X:153001636 C/T).
153001640 c.1156A>G p.Thr386Ala exon 3 VUS (X:153001640 A/G) frequency 1/178645 control alleles.
153001640 c.1156A>T p.Thr386Ser exon 3 VUS (X:153001640 A/T) frequency 1/21583 control alleles.
153001639 c.1155del p.Phe385Leufs*8 exon 3 Pathogenic, identified in ALD patient (90). Deleterious mutation.
153001643 c.1159del p.Ile387Leufs*6 exon 3 Pathogenic, identified in ALD patient (33). Deleterious mutation.
153001647 c.1163_64insG p.Arg389Profs*12 exon 3 Pathogenic, identified in ALD patient (58). Deleterious mutation. No detectable ALDP in patient cells (58).
153001649 c.1165C>G p.Arg389Gly exon 3 Pathogenic, identified in 3 ALD patients (15, 60, 100).
153001649 c.1165C>T p.Arg389Cys exon 3 Pathogenic, identified in 6 ALD patients (58, 98).
153001649 c.[1165C>T; 1224+1GT>TG] p.[Arg389Cys; Val409fs*?] IVS 3 + exon 3 Pathogenic, identified in ALD patient (33). Deleterious mutation.
153001650 c.1166G>A p.Arg389His exon 3 Pathogenic, identified in 25 ALD patients (13, 16, 22, 32, 60, 97, 111, 139, 141, 146, 178). Reduced (41% of control cells) ALDP in patient cells (139, 141).
153001655 c.1171_80del p.Leu391Argfs*16 exon 3 Pathogenic, identified in 2 ALD patients (60). Deleterious mutation.
153001656 c.1172T>C p.Leu391Pro exon 3 Pathogenic, identified in ALD patient (68).
153001656 c.1172T>G p.Leu391Arg exon 3 VUS (X:153001656 T/G) frequency 1/178700 control alleles
153001658 c.1174C>G p.Leu392Val exon 3 Pathogenic, identified in 2 ALD patients (33, 88).
153001658 c.1174_81delinsAAT p.Leu392Asnfs*7 exon 3 Pathogenic, identified in ALD patient (130). Deleterious mutation.
153001663 c.1179A>C p.Thr393Thr exon 3 Synonymous (X:153001663 A/C).
153001663 c.1179_80del p.Ala394Glyfs*6 exon 3 Pathogenic, identified in ALD patient (33). Deleterious mutation.
153001664 c.1180del p.Ala394Argfs*16 exon 3 Pathogenic, identified in 3 ALD patients (120). Deleterious mutation.
153001666 c.1182G>A p.Ala394Ala exon 3 Synonymous (X:153001666 G/A).
153001667 c.1183del p.Ala395Leufs*15 exon 3 Pathogenic, identified in ALD patient (125). Deleterious mutation.
153001670 c.1186G>A p.Ala396Thr exon 3 Pathogenic, identified in 7 ALD patients (33, 60, 181). No detectable ALDP in patient cells (60).
153001674 c.1190A>G p.Asp397Gly exon 3 VUS (X:153001674 A/G) frequency 1/178725 control alleles.
153001681 c.1197T>C p.Ile399Ile exon 3 Synonymous (X:153001681 T/C).
153001685 c.1201C>A p.Arg401Arg exon 3 Synonymous (X:153001685 C/A).
153001685 c.1201C>T p.Arg401Trp exon 3 Pathogenic, identified in 18 ALD patients (24, 29, 32, 33, 51, 87, 88, 90, 96, 100, 145, 154).
153001685 c.1201C>G p.Arg401Gly exon 3 Pathogenic, identified in 2 ALD patients (100, 154).
153001686 c.1202G>A p.Arg401Gln exon 3 Pathogenic, identified in 38 ALD patients (8, 15, 22, 29, 32, 33, 40, 47, 49, 60, 71, 72, 86, 88, 93, 98, 105, 125, 126, 150, 158). Normal ALDP level in patient cells (22, 32, 33, 49, 60, 72), but non-functional.
153001689 c.1205T>A p.Ile402Asn exon 3 Pathogenic, identified in 2 ALD patients (131). No detectable ALDP in patient cells (131).
153001694 c.1210T>C p.Ser404Pro exon 3 Pathogenic, identified in 3 ALD patients (59, 64, 132).
153001695 c.1211C>A p.Ser404* exon 3 Pathogenic, identified in ALD patient (98). Deleterious mutation.
153001695 c.1211C>T p.Ser404Leu exon 3 VUS (X:153001695 C/T) frequency 1/178707 control alleles.
153001696 c.1212_14del p.Ser405del exon 3 Pathogenic, identified in ALD patient (84).
153001696 c.1212G>A p.Ser404Ser exon 3 Synonymous (X:153001696 G/A).
153001697 c.1213T>C p.Ser405Pro exon 3 Pathogenic, identified in ALD patient (137).
153001698 c.1214C>A p.Ser405* exon 3 Pathogenic, identified in ALD patient (145). Deleterious mutation.
153001699 c.1215G>A p.Ser405Ser exon 3 Synonymous (X:153001699 G/A).
153001703 c.1219A>T p.Lys407* exon 3 Pathogenic, identified in 2 ALD patients (33, 49). Deleterious mutation.
153001708 c.1224G>A p.Val409fs*? exon 3 Pathogenic, identified in 2 ALD patients (13). Deleterious mutation.
153001709 c.1224+1GT>TG p.Val409fs*? IVS 3 Pathogenic, identified in ALD patient (58). Deleterious mutation.
153001710 c.1224+2T>C p.Val409fs*? IVS 3 Pathogenic, identified in ALD patient (64). Deleterious mutation.
153001710 c.1224+2T>G p.Val409fs*? IVS 3 Pathogenic, identified in ALD patient (103). Deleterious mutation.
153001713 c.1224+5C>T IVS 3 VUS (X:153001713 C/T).
153001773 c.1225-26G>T IVS 3 VUS (X:153001773 G/T) frequency 9/178416 control alleles.
153001790 c.1225-9C>T IVS 3 VUS (X:153001790 C/T).
153001791 c.1225-8T>A IVS 3 VUS (X:153001791 T/A) frequency 1/178537 control alleles.
153001792 c.1225-7_1239del22 p.Val409fs*? IVS 3 Pathogenic, identified in ALD patient (33). Deleterious mutation.
153001797 c.1225-2A>C p.Val409fs*? IVS 3 Pathogenic, identified in ALD patient (33). Deleterious mutation.
153001797 c.1225-2A>G p.Val409fs*? IVS 3 Pathogenic, identified in ALD patient (96). Deleterious mutation.
153001802 c.1228A>T p.Thr410Ser exon 4 VUS (X:153001802 A/T) frequency 4/178585 control alleles.
153001803 c.1229C>A p.Thr410Lys exon 4 VUS (X:153001803 C/A) frequency 1/178582 control alleles.
153001803 c.1229C>T p.Thr410Met exon 4 VUS (X:153001803 C/T) frequency 3/178582 control alleles.
153001804 c.1230G>A p.Thr410Thr exon 4 Synonymous (X:153001804 G/A).
153001811 c.1237G>A p.Ala413Pro exon 4 Pathogenic, identified in ALD patient (33).
153001811 c.1237G>C p.Ala413Pro exon 4 Pathogenic, identified in ALD patient (33).
153001812 c.1238C>G p.Ala413Gly exon 4 VUS (X:153001812 C/G) frequency 1/178591 control alleles.
153001813 c.1239T>C p.Ala413Ala exon 4 Synonymous (X:153001813 T/C).
153001818 c.1244A>G p.Tyr415Cys exon 4 Pathogenic, identified in ALD patient (84).
153001819 c.1245C>T p.Tyr415Tyr exon 4 Synonymous (X:153001819 C/T).
153001822 c.1248del p.Ala417Profs*24 exon 4 Pathogenic, identified in ALD patient (33). Deleterious mutation.
153001824 c.1250del p.Arg418Glyfs*23 exon 4 Pathogenic, identified in ALD patient (7). Deleterious mutation. No detectable ALDP in patient cells (7).
153001826 c.1252C>T p.Arg418Trp exon 4 Pathogenic, identified in 18 ALD patients (8, 15, 29, 33, 40, 58, 145, 177, 178). Affects ALDP stability in patient cells (33, 58, 165).
153001827 c.1253G>A p.Arg418Gln exon 4 VUS (X:153001827 G/A) frequency 1/178560 control alleles.
153001829 c.1255G>A p.Val419Met exon 4 VUS (X:153001829 G/A) frequency 4/178589 control alleles.
153001829 c.1255G>C p.Val419Leu exon 4 VUS (X:153001829 G/C) frequency 1/178589 control alleles.
153001833 c.1259A>C p.His420Pro exon 4 Pathogenic, identified in ALD patient (104).
153001834 c.1260C>A p.His420Gln exon 4 VUS (X:153001834 C/A) frequency 7/178596 control alleles.
153001835 c.1261G>A p.Glu421Lys exon 4 VUS (X:153001835 G/A) frequency 1/178608 control alleles.
153001837 c.1263delG p.Met422Cysfs*19 exon 4 Pathogenic, identified in ALD patient (33). Deleterious mutation.
153001841 c.1267T>A p.Phe423Ile exon 4 VUS (X:153001841 T/A) frequency 1/178615 control alleles.
153001842 c.1268T>C p.Phe423Ser exon 4 Pathogenic, identified in ALD patient (145).
153001844 c.1270C>T p.Gln424* exon 4 Pathogenic, identified in 2 ALD patients (32). Deleterious mutation.
153001844 c.1270delC p.Gln424Argfs*17 exon 4 Pathogenic, identified in ALD patient (52). Deleterious mutation.
153001847 c.1273G>A p.Val425Ile exon 4 VUS (X:153001847 G/A).
153001853 c.1279_81del p.Glu427del exon 4 Pathogenic, identified in ALD patient (49).
153001862 c.1288C>T p.Gln430* exon 4 Pathogenic, identified in ALD patient (49). Deleterious mutation.
153001862 c.[1288C>T; 1390C>T] p.[Gln430*; Arg464*] exon 4 + exon 4 Pathogenic, identified in ALD patient (33). Two deleterious mutations.
153001865 c.1291C>T p.Arg431Cys exon 4 VUS (X:153001865 C/T) frequency 1/178596 control alleles.
153001866 c.1292G>A p.Arg431His exon 4 VUS (X:153001866 G/A) frequency 2/178590 control alleles.
153001869 c.1295G>A p.Cys432Tyr exon 4 VUS (X:153001869 G/A) frequency 1/178586 control alleles.
153001873 c.1299C>T p.His433His exon 4 Synonymous (X:153001873 C/T).
153001878 c.1304A>G p.Lys435Arg exon 4 VUS (X:153001878 A/G) frequency 1/178568 control alleles.
153001889 c.1315G>T p.Glu439* exon 4 Pathogenic, identified in ALD patient (58). Deleterious mutation. No detectable ALDP in patient cells (58).
153001891 c.1317G>A p.Glu439Glu exon 4 Synonymous (X:153001891 G/A).
153001896 c.1322dupA p.Asp442Glyfs*114 exon 4 Pathogenic, identified in 3 ALD patients (32, 141). Deleterious mutation. No detectable ALDP in patient cells (32, 141).
153001900 c.1326C>G p.Asp442Glu exon 4 VUS (X:153001900 C/G) frequency 1/178469 control alleles.
153001900 c.1326C>T p.Asp442Asp exon 4 Synonymous (X:153001900 C/T).
153001901 c.1327G>A p.Ala443Thr exon 4 VUS (X:153001901 G/A) frequency 4/178453 control alleles.
153001904 c.1330C>T p.Gln444* exon 4 Pathogenic, identified in 3 ALD patients (32, 60). Deleterious mutation.
153001908 c.1334C>T p.Ala445Val exon 4 VUS (X:153001908 C/T) frequency 2/178358 control alleles
153001909 c.1335G>A p.Ala445Ala exon 4 Synonymous (X:153001909 G/A).
153001921 c.1347C>T p.Thr449Thr exon 4 Synonymous (X:153001921 C/T).
153001924 c.1350A>G p.Ile450Met exon 4 VUS (X:153001924 A/G) frequency 2/178260 control alleles.
153001928 c.1354C>T p.Arg452Trp exon 4 Benign, based on its frequency of 92/199674 control alleles (X:153001928 C/T).
153001929 c.1355G>T p.Arg452Leu exon 4 VUS (X:153001929 G/T) frequency 1/178072 control alleles.
153001929 c.1355G>A p.Arg452Gln exon 4 VUS (X:153001929 G/A) frequency 3/178072 control alleles.
153001932 c.1358delinsGA p.Ser453* exon 4 Pathogenic, identified in ALD patient (58). Deleterious mutation.
153001933 c.1359delT p.Gly454Valfs*8 exon 4 Pathogenic, identified in ALD patient (60). Deleterious mutation. No detectable ALDP in patient cells (60).
153001940 c.1366C>T p.Arg456Cys exon 4 VUS (X:153001940 C/T) frequency 2/177723 control alleles.
153001941 c.1367G>A p.Arg456His exon 4 VUS (X:153001941 G/A) frequency 7/177689 control alleles.
153001941 c.1367G>T p.Arg456Leu exon 4 VUS (X:153001941 G/T) frequency 1/177689 control alleles.
153001941 c.1367G>C p.Arg456Pro exon 4 VUS (X:153001941 G/C) frequency 1/177689 control alleles.
153001943 c.1369G>C p.Val457Leu exon 4 VUS (X:153001943 G/C) frequency 1/177679 control alleles.
153001946 c.1372G>T p.Glu458* exon 4 Pathogenic, identified in ALD patient (29). Deleterious mutation.
153001961 c.1387A>T p.Ile463Phe exon 4 VUS (X:153001961 A/T) frequency 1/176350 control alleles.
153001964 c.1390C>T p.Arg464* exon 4 Pathogenic, identified in 19 ALD patients (6, 32, 33, 47, 49, 59, 62, 64, 96, 105, 132, 141). Deleterious mutation. No detectable ALDP in patient cells (6, 32, 77, 141).
153001964 c.1390_91insA p.Arg464Glnfs*92 exon 4 Pathogenic, identified in ALD patient (33). Deleterious mutation.
153001965 c.1391G>A p.Arg464Gln exon 4 VUS (X:153001965 G/A) frequency 6/197263 control alleles.
153001965 c.1391G>C p.Arg464Pro exon 4 VUS (X:153001965 G/C) frequency 3/175733 control alleles.
153001968 c.1393+1G>A p.Val425fs*92 IVS 4 Pathogenic, identified in ALD patient (135). Activation of cryptic spice site, confirmed by functional studies (135).
153001969 c.1393+2T>A p.Phe426Argfs*92 IVS 4 Pathogenic, identified in 6 ALD patients (159). Activation of cryptic spice site, confirmed by functional studies (159).
153002609 c.1394-2A>G p.Gly465fs*? IVS 4 Pathogenic, identified in 4 ALD patients (32, 71, 75, 150). Activation of cryptic spice site, confirmed by functional studies (75).
153002613 c.1396C>T p.Gln466* exon 5 Pathogenic, identified in 3 ALD patients (13, 32, 158). Deleterious mutation. No detectable ALDP in patient cells (32).
153002616 c.1399G>A p.Val467Met exon 5 VUS (X:153002616 G/A) frequency 1/177603 control alleles.
153002616 c.[1399G>A; 1850G>A] p.[Val467Met; Arg617His] exon 5 + exon 8 Pathogenic, identified in ALD patient (33). p.Val467Met is a VUS; p.Arg617His is a true pathogenic mutation.
153002617 c.1400_05del p.Val467_Val468del exon 5 Pathogenic, identified in 2 ALD patients (143).
153002619 c.1402G>A p.Val468Met exon 5 VUS (X:153002619 G/A) frequency 1/177657 control alleles.
153002621 c.1404G>A p.Val468Val exon 5 Synonymous (X:153002621 G/A).
153002628 c.1411_12insA p.Gln472Thrfs*84 exon 5 Pathogenic, identified in 2 ALD patients (13). Deleterious mutation.
153002629 c.1412_13del p.Glu471Alafs*84 exon 5 Pathogenic, identified in 2 ALD patients (13). Deleterious mutation.
153002630 c.1413A>G p.Glu471Glu exon 5 Synonymous (X:153002630 A/G).
153002631 c.1414dupC p.Gln472Profs*84 exon 5 Pathogenic, identified in ALD patient (47). Deleterious mutation.
153002632 c.1415_16delAG p.Gln472Argfs*83 exon 5 Pathogenic, identified in 137 ALD patients (1, 7, 8, 10, 13, 15, 16, 22, 24, 29, 32, 33, 36, 40, 43, 48,, 49, 53, 58, 59, 60, 62, 63, 64, 85, 86, 88, 90, 93, 100, 105, 108, 110, 119, 120, 125, 132, 145, 146, 158, 164, 169, 174, 178). Deleterious mutation. No detectable ALDP in patient cells (7, 22, 32, 36, 53, 58, 60, 146).
153002633 c.1416_17del p.Gly473Aspfs*82 exon 5 Pathogenic, identified in ALD patient (33). Deleterious mutation.
153002637 c.1420del p.Ile474Serfs*84 exon 5 Pathogenic, identified in ALD patient (60). Deleterious mutation. No detectable ALDP in patient cells(60).
153002639 c.1421T>C p.Ile474Thr exon 5 Pathogenic, identified in 4 ALD patients (33, 88, 125).
153002638 c.1422_26del p.Ile474Metfs*80 exon 5 Pathogenic, identified in ALD patient (66). Deleterious mutation.
153002643 c.1426T>G p.Cys476Gly exon 5 VUS (X:153002643 T/G) frequency 1/177774 control alleles
153002645 c.1428C>A p.Cys476* exon 5 Pathogenic, identified in ALD patient (125). Deleterious mutation.
153002645 c.1428C>G p.Cys476Trp exon 5 VUS (X:153002645 C/G) frequency 1/177715 control alleles.
153002645 c.1428C>T p.Cys476Cys exon 5 Synonymous (X:153002645 C/T).
153002646 c.1429G>A p.Glu477Lys exon 5 VUS (X:153002646 G/A) frequency 4/177731 control alleles.
153002646 c.1429G>T p.Glu477* exon 5 Pathogenic, identified in 4 ALD patients (8, 15, 33). Deleterious mutation.
153002647 c.1430del p.Glu477Glyfs*81 exon 5 Pathogenic, identified in 3 ALD patients (91, 100). Deleterious mutation.
153002653 c.1436del p.Ile479Thrfs*79 exon 5 Pathogenic, identified in ALD patient (33). Deleterious mutation.
153002658 c.1441A>T p.Ile481Phe exon 5 Pathogenic, identified in ALD patient (100).
153002658 c.1441A>G p.Ile481Val exon 5 VUS (X:153002658 A/G) frequency 1/177634 control alleles.
153002660 c.1443C>T p.Ile481Ile exon 5 Synonymous (X:153002660 C/T).
153002661 c.1444G>A p.Val482Ile exon 5 VUS (X:153002661 G/A) frequency 8/199256 control alleles.
153002662 c.1445T>A p.Val482Asp exon 5 Pathogenic, identified in ALD patient (142).
153002668 c.1451C>G p.Pro484Arg exon 5 Pathogenic, identified in 5 ALD patients (3).
153002669 c.1452C>G p.Pro484Pro exon 5 Synonymous (X:153002669 C/G).
153002671 c.1454C>A p.Ser485* exon 5 Pathogenic, identified in ALD patient (33). Deleterious mutation.
153002672 c.1455A>C p.Ser485Ser exon 5 Synonymous (X:153002672 A/C).
153002672 c.1455_59delinsGGGA p.Glu487Argfs*71 exon 5 Pathogenic, identified in ALD patient (33). Deleterious mutation.
153002673 c.1456G>A p.Gly486Arg exon 5 VUS (X:153002673 G/A) frequency 5/176936 control alleles.
153002679 c.1462_63insTGG p.Val488_Val489insVal exon 5 Pathogenic, identified in ALD patient (58). No detectable ALDP in patient cells (58).
153002684 c.1467G>A p.Val489Val exon 5 Synonymous (X:153002684 G/A).
153002686 c.1469_71del p.Val490del exon 5 Pathogenic, identified in ALD patient (33).
153002687 c.1470_71insGTG p.Val490_Ala491insVal exon 5 Pathogenic, identified in ALD patient (7). No detectable ALDP in patient cells (7).
153002687 c.1470_72dup p.Ala491dup exon 5 Pathogenic, identified in ALD patient (33).
153002694 c.1477_1488+11del p.Leu493_Arg496del exon 5 Pathogenic, identified in ALD patient (108).
153002695 c.1478T>C p.Leu493Pro exon 5 Pathogenic, identified in 2 ALD patients (33, 88).
153002698 c.1481del p.Asn494Thrfs*64 exon 5 Pathogenic, identified in ALD patient (33). Deleterious mutation.
153002704 c.1487G>C p.Arg496Thr exon 5 VUS (X:153002704 G/C) frequency 1/174592 control alleles.
153002706 c.1488+1G>A p.Val497fs*? IVS 5 Pathogenic, identified in 2 ALD patients (33, 40). Deleterious mutation.
153002708 c.1488+3A>G p.Val497fs*? IVS 5 Pathogenic, identified in 4 ALD patients (32). Deleterious mutation.
153005536 c.1489-10delC IVS 5 Benign, based on its frequency of 1374/197671 control alleles (X:153005536 GC/G). East-Asian specific polymorphism (1286/13873 control alleles) confirmed by pedigree analysis (68).
153005537 c.1489-9C>T IVS 5 VUS (X:153005537 C/T).
153005540 c.1489-6delC IVS 5 Benign, based on its frequency of 1374/197671 control alleles (X:153005536 GC/G). East-Asian specific polymorphism (1286/13873 control alleles) confirmed by pedigree analysis (68).
153005545 c.1489-1_1489delinsTT p.Val497fs*? IVS 5 Pathogenic, identified in ALD patient (33). Deleterious mutation.
153005546 c.1489G>A p.Val497Met exon 6 VUS (X:153005546 G/A) frequency 1/176603 control alleles
153005554 c.1497_1505del p.Glu499_His502delinsAsp exon 6 Pathogenic, identified in ALD patient (105).
153005556 c.1499G>T p.Gly500Val exon 6 Pathogenic, identified in ALD patient (33).
153005558 c.1501A>C p.Met501Leu exon 6 Pathogenic, identified in ALD patient (60). Normal ALDP level in patient cells (60), but non-functional
153005562 c.1505_06insC p.Leu503Serfs*53 exon 6 Pathogenic, identified in ALD patient (33). Deleterious mutation.
153005565 c.1505_10del p.Leu503_Leu504del exon 6 Pathogenic, identified in ALD patient (58).
153005562 c.1508T>C p.Leu503Pro exon 6 Pathogenic, identified in 2 ALD patients (63, 146).
153005565 c.1508_09insC p.Leu504Alafs*52 exon 6 Pathogenic, identified in ALD patient (27). Deleterious mutation.
153005572 c.1514T>C p.Ile505Thr exon 6 Pathogenic, identified in ALD patient (33).
153005571 c.1515C>G p.Ile505Met exon 6 Pathogenic, identified in ALD patient (32, 58). Affects ALDP stability in patient cells (32, 58).
153005572 c.1515_19delinsGCA p.Ile505Metfs*50 exon 6 Pathogenic, identified in ALD patient (60). Deleterious mutation.
153005576 c.1519G>A p.Gly507Ser exon 6 Pathogenic, identified in 3 ALD patients (32).
153005577 c.1520G>A p.Gly507Asp exon 6 Pathogenic, identified in 2 ALD patients (68, 88).
153005577 c.1520G>T p.Gly507Val exon 6 Pathogenic, identified in ALD patient (24).
153005578 c.1521C>T p.Gly507Gly exon 6 Synonymous (X:153005578 C/T).
153005580 c.1523C>T p.Pro508Leu exon 6 Pathogenic, identified in ALD patient (93).
153005583 c.1526A>G p.Asn509Ser exon 6 VUS (X:153005583 A/G) frequency 1/177654 control alleles.
153005583 c.1526A>T p.Asn509Ile exon 6 Pathogenic, identified in 4 ALD patients (33, 64, 132, 137).
153005585 c.1528G>A p.Gly510Ser exon 6 Pathogenic, identified in 2 ALD patients (33, 100).
153005586 c.1529G>A p.Gly510Asp exon 6 Pathogenic, identified in 5ALD patients (33, 59, 64, 132, 137).
153005588 c.1531T>C p.Cys511Arg exon 6 Pathogenic, identified in ALD patient (33).
153005589 c.1532G>A p.Cys511Tyr exon 6 Pathogenic, identified in 2 ALD patients (33, 137).
153005590 c.1533C>T p.Cys511Cys exon 6 Synonymous (X:153005590 C/T).
153005590 c.1533C>A p.Cys511* exon 6 Pathogenic, identified in 2 ALD patients (33, 49). Deleterious mutation.
153005590 c.1533C>G p.Cys511Trp exon 6 Pathogenic, identified in ALD patient (137).
153005591 c.1534G>T p.Gly512Cys exon 6 Pathogenic, identified in ALD patient (47).
153005591 c.1534G>A p.Gly512Ser exon 6 Pathogenic, identified in 31 ALD patients (7, 13, 23, 27, 33, 53, 57, 58, 76, 88, 93, 100, 108, 121, 124, 153, 154, 158, 178, 181, 185). No detectable ALDP in patient cells (7, 23, 53, 58).
153005593 c.1536C>G p.Gly512Gly exon 6 Synonymous (X:153005593 C/G).
153005594 c.1537A>C p.Lys513Gln exon 6 Pathogenic, identified in 2 ALD patients (33, 69).
153005595 c.1538A>G p.Lys513Arg exon 6 Pathogenic, identified in 2 ALD patients (58, 125). No detectable ALDP in patient cells (58).
153005597 c.1540A>C p.Ser514Arg exon 6 Pathogenic, identified in 5 ALD patienst (63, 145).
153005597 c.1540A>G p.Ser514Gly exon 6 Pathogenic, identified in 2 ALD patienst (32).
153005598 c.1541G>T p.Ser514Ile exon 6 Pathogenic, identified in 2 ALD patients (88).
153005598 c.1541G>A p.Ser514Asn exon 6 Pathogenic, identified in 2 ALD patients (58, 145). Affects ALDP stability in patient cells (58).
153005601 c.1544C>A p.Ser515Tyr exon 6 Pathogenic, identified in ALD patient (125).
153005601 c.1544C>T p.Ser515Phe exon 6 Pathogenic, identified in 11 ALD patients (8, 51, 112, 179).
153005604 c.1547T>C p.Leu516Pro exon 6 Pathogenic, identified in 5 ALD patients (33, 58, 71, 150). No detectable ALDP in patient cells (58).
153005605 c.1548G>A p.Leu516Leu exon 6 Synonymous (X:153005605 G/A).
153005608 c.1551C>T p.Phe517Phe exon 6 Synonymous (X:153005608 C/T).
153005608 c.1551del p.Arg518Glyfs*40 exon 6 Pathogenic, identified in 2 ALD patients (6, 33). Deleterious mutation.
153005609 c.1552C>G p.Arg518Gly exon 6 Pathogenic, identified in 4 ALD patients (59, 64, 132, 137).
153005609 c.1552C>T p.Arg518Trp exon 6 Pathogenic, identified in 19 ALD patients (6, 7, 32, 33, 53, 58, 88, 90, 125, 133, 137). No detectable ALDP in patient cells (7, 58).
153005610 c.1553G>A p.Arg518Gln exon 6 Pathogenic, identified in 45 ALD patients (9, 24, 32, 33, 48, 49, 53, 58, 59, 60, 64, 88, 90, 96, 100, 105, 108, 120, 132, 137, 154, 181). No detectable ALDP in patient cells (9, 32, 49, 53, 58, 60).
153005616 c.1559T>A p.Leu520Gln exon 6 Pathogenic, identified in 5 ALD patients (54, 59, 64, 132, 137).
153005621 c.1564G>A p.Gly522Arg exon 6 Pathogenic, identified in 2 ALD patients (7, 58). No detectable ALDP in patient cells (7, 58).
153005624 c.1567C>T p.Leu523Phe exon 6 Pathogenic, identified in ALD patient (96).
153005625 c.1568T>C p.Leu523Pro exon 6 Pathogenic, identified in ALD patient (33).
153005627 c.1570T>C p.Trp524Arg exon 6 Pathogenic, identified in ALD patient (33).
153005628 c.1571G>A p.Trp524* exon 6 Pathogenic, identified in ALD patient (60). Deleterious mutation. No detectable ALDP in patient cells (60).
153005630 c.1573C>G p.Pro525Ala exon 6 Pathogenic, identified in ALD patient (33).
153005630 c.1573C>T p.Pro525Ser exon 6 Pathogenic, identified in ALD patient (58). No detectable ALDP in patient cells (58).
153005638 c.1581C>T p.Tyr527Tyr exon 6 Synonymous (X:153005638 C/T).
153005638 c.1581C>A p.Tyr527* exon 6 Pathogenic, identified in ALD patient (105). Deleterious mutation.
153005639 c.1582G>A p.Gly528Ser exon 6 Benign, (X:153005639 G/A) frequency 8/199702 control alleles, confirmed by biochemical testing (144).
153005642 c.1585G>A p.Gly529Ser exon 6 Pathogenic, identified in ALD patient (38).
153005642 c.1585_87del p.Gly529del exon 6 Pathogenic, identified in 2 ALD patients (4, 105).
153005642 c.1585delG p.Gly529Valfs*29 exon 6 Pathogenic, identified in 2 ALD patients (21, 62). Deleterious mutation.
153005643 c.1586_90del p.Gly529Valfs*25 exon 6 Pathogenic, identified in ALD patient (49). Deleterious mutation. No detectable ALDP in patient cells (49).
153005643 c.1586G>A p.Gly529Asp exon 6 Pathogenic, identified in 2 ALD patients (33).
153005645 c.1588G>A p.Val530Met exon 6 VUS (X:153005645 G/A) frequency 1/178126 control alleles
153005649 c.1592_93insT p.Tyr532Leufs*24 exon 6 Pathogenic, identified in ALD patient (38). Deleterious mutation.
153005654 c.1597A>C p.Lys533Gln exon 6 Status unresolved, identified in newborn screening (181). Functional testing pending.
153005654 c.1597A>G p.Lys533Glu exon 6 Pathogenic, identified in 2 ALD patients (33, 60). No detectable ALDP in patient cells (60).
153005655 c.1598A>G p.Lys533Arg exon 6 Pathogenic, identified in ALD patient (183).
153005656 c.1598_99insA p.Pro534Alafs*22 exon 6 Pathogenic, identified in ALD patient (33). Deleterious mutation.
153005656 c.1599G>T p.Lys533Asn exon 6 Pathogenic, identified in ALD patient (84).
153005657 c.1599delG p.Lys533Asnfs*25 exon 6 Pathogenic, identified in ALD patient (49). Deleterious mutation. No detectable ALDP in patient cells (49).
153005658 c.1600C>T p.Pro534Ser exon 6 Pathogenic, identified in ALD patient (33).
153005658 c.1601C>G p.Pro534Arg exon 6 Pathogenic, identified in 5 ALD patients (67, 86, 93, 132, 137).
153005655 c.1601C>T p.Pro534Leu exon 6 Pathogenic, identified in ALD patient (23). No detectable ALDP in patient cells (23).
153005660 c.1603_04del p.Pro535Thrfs*20 exon 6 Pathogenic, identified in 3 ALD patients (59, 64, 132). Deleterious mutation.
153005660 c.1603_1991del p.Pro535Glufs*69 exon 6 Pathogenic, identified in 7 ALD patients (16, 32). Deleterious mutation. No detectable ALDP in patient cells (32).
153005664 c.1607C>A p.Pro536His exon 6 Pathogenic, identified in ALD patient (84).
153005666 c.1609C>T p.Gln537* exon 6 Pathogenic, identified in ALD patient (96). Deleterious mutation.
153005668 c.1611G>C p.Gln537His exon 6 VUS (X:153005668 G/C) frequency 2/178177 control alleles.
153005669 c.1612C>T p.Arg538Cys exon 6 VUS (X:153005669 C/T) frequency 1/178116 control alleles.
153005670 c.1613G>A p.Arg538His exon 6 VUS (X:153005670 G/A).
153005672 c.1615A>C p.Met539Leu exon 6 VUS (X:153005672 A/C) frequency 3/199708 control alleles.
153005672 c.1615A>T p.Met539Leu exon 6 VUS (X:153005672 A/T) frequency 1/178110 control alleles.
153005674 c.1617G>A p.Met539Ile exon 6 VUS (X:153005674 G/A) frequency 1/178094 control alleles.
153005676 c.1619T>C p.Phe540Ser exon 6 Pathogenic, identified in ALD patient (24).
153005676 c.1619T>G p.Phe540Cys exon 6 Pathogenic, identified in ALD patient (96).
153005677 c.1620C>T p.Phe540Phe exon 6 Synonymous (X:153005677 C/T).
153005681 c.1624_26del p.Ile542del exon 6 Pathogenic, identified in ALD patient (68).
153005684 c.1627C>T p.Pro543Ser exon 6 Pathogenic, identified in ALD patient (186).
153005685 c.1628C>T p.Pro543Leu exon 6 Pathogenic, identified in 36 ALD patients (27, 29, 32, 33, 40, 49, 60, 65, 114, 139, 141, 145, 158, 178). No detectable ALDP in patient cells (32, 49, 60, 139, 141).
153005685 c.1628delC p.Pro543Argfs*15 exon 6 Pathogenic, identified in ALD patient (33). Deleterious mutation.
153005685 c.1628_34dup p.Arg545serfs*13 exon 6 Pathogenic, identified in 2 ALD patients (32, 49). Deleterious mutation. No detectable ALDP in patient cells (32).
153005686 c.1629G>A p.Pro543Pro exon 6 Synonymous (X:153005686 G/A).
153005687 c.1630C>A p.Gln544Lys exon 6 Pathogenic, identified in ALD patient (58). Affects ALDP stability in patient cells (58).
153005688 c.1631A>G p.Gln544Arg exon 6 Pathogenic, identified in 6 ALD patients (9, 24, 33, 88, 90). Normal ALDP level in patient cells (9), but non-functional
153005690 c.1633A>T p.Arg545Trp exon 6 Pathogenic, identified in ALD patient (53).
153005691 c.1634G>A p.Arg545Lys exon 6 VUS (X:153005691 G/A) frequency 1/177632 control alleles.
153005692 c.1634+1G>A p.Pro546fs*? IVS 6 Pathogenic, identified in 4 ALD patients (6, 49, 60, 132). Deleterious mutation.
153005692 c.1634+1G>C p.Pro546fs*? IVS 6 Pathogenic, identified in ALD patient (33). Deleterious mutation.
153005695 c.1634+4A>G IVS 6 VUS (X:153005695 A/G).
153005696 c.1634+5G>C IVS 6 VUS (X:153005696 G/C).
153006013 c.1635-16_1645delins CACAGACATGTAGGGC p.Pro546fs*? IVS 6 Pathogenic, identified in ALD patient (181). Deleterious mutation.
153006022 c.1635-6C>T IVS 6 VUS (X:153006022 C/T) frequency 3/199784 control alleles.
153006025 c.1635-3C>G p.Pro546fs*? IVS 6 Pathogenic, identified in ALD patient (33). Deleterious mutation.
153006026 c.1635-2A>G p.Pro546fs*? IVS 6 Pathogenic, identified in 5 ALD patients (11, 33). Deleterious mutation. No detectable ALDP in patient cells (33) due to splicing defect (11).
153006033 c.1640A>G p.Tyr547Cys exon 7 Pathogenic, identified in 3 ALD patients (33, 104, 124). No detectable ALDP in patient cells (104).
153006046 c.1653C>T p.Gly551Gly exon 7 Synonymous (X:153006046 C/T).
153006046 c.1653insG p.Ser552fs*3 exon 7 Pathogenic, identified in ALD patient (100). Deleterious mutation.
153006047 c.1654T>C p.Ser552Pro exon 7 Pathogenic, identified in 2 ALD patients (28, 33).
153006050 c.1657C>G p.Leu553Val exon 7 Pathogenic, identified in ALD patient (33).
153006053 c.1660C>T p.Arg554Cys exon 7 VUS (X:153006053 C/T).
153006054 c.1661G>A p.Arg554His exon 7 Pathogenic, identified in 44 ALD patients (28, 29, 32, 33, 49, 52, 58, 59, 60, 62, 63, 64, 87, 88, 97, 100, 102, 107, 108, 111, 120, 132, 137, 145, 178). No detectable (1% of controls (97)) ALDP in patient cells (32, 49, 58, 60, 97, 102).
153006056 c.1663G>A p.Asp555Asn exon 7 Pathogenic, identified in ALD patient (52).
153006059 c.1666C>T p.Gln556* exon 7 Pathogenic, identified in ALD patient (58). Deleterious mutation. No detectable ALDP in patient cells (58).
153006060 c.1667A>G p.Gln556Arg exon 7 Pathogenic, identified in 5 ALD patients (40, 59, 64, 132, 137).
153006063 c.1670_71del p.Val557Aspfs*43 exon 7 Pathogenic, identified in ALD patient (49). Deleterious mutation.
153006066 c.1673T>C p.Ile558Thr exon 7 Pathogenic, identified in ALD patient (72). Normal ALDP level in patient cells (72).
153006069 c.1676A>G p.Tyr559Cys exon 7 Pathogenic, identified in 4 ALD patients (32, 33).
153006070 c.1677C>G p.Tyr559* exon 7 Pathogenic, identified in ALD patient (122). Deleterious mutation.
153006071 c.1678C>T p.Pro560Ser exon 7 Pathogenic, identified in ALD patient (49).
153006072 c.1679C>T p.Pro560Leu exon 7 Pathogenic, identified in 39 ALD patients (4, 7, 24, 32, 33, 49, 71, 86, 88, 90, 93, 96, 100, 108, 111, 136, 145, 150, 158, 165). Affects ALDP stability in patient cells (7, 32, 33, 49).
153006072 c.1679C>G p.Pro560Arg exon 7 Pathogenic, identified in ALD patient (7). No detectable ALDP in patient cells (7).
153006073 c.1680G>A p.Pro560Pro exon 7 Synonymous (X:153006073 G/A).
153006075 c.1682A>T p.Asp561Val exon 7 Pathogenic, identified in 3 ALD patients (60). No detectable ALDP in patient cells (60).
153006087 c.1694A>G p.Asp565Gly exon 7 VUS (X:153006087 A/G) frequency 1/178467 control alleles
153006090 c.1697T>A p.Met566Lys exon 7 Pathogenic, identified in 2 ALD patients (13). No detectable ALDP in patient cells (33).
153006090 c.1697T>C p.Met566Thr exon 7 Pathogenic, identified in ALD patient (58). No detectable ALDP in patient cells (58).
153006092 c.1699C>T p.Gln567* exon 7 Pathogenic, identified in 2 ALD patients (33, 60). Deleterious mutation.
153006107 c.1714_25del p.Ser572_Asp575del exon 7 Pathogenic, identified in 2 ALD patients (81, 104).
153006108 c.1715C>T p.Ser572Leu exon 7 VUS (X:153006108 C/T) frequency 1/178412 control alleles.
153006108 c.1715C>A p.Ser572* exon 7 Pathogenic, identified in ALD patient (60). Deleterious mutation. No detectable ALDP in patient cells (60).
153006110 c.1717delG p.Glu573Serfs*63 exon 7 Pathogenic, identified in ALD patient (33). Deleterious mutation.
153006113 c.1720C>T p.Gln574* exon 7 Pathogenic, identified in ALD patient (53, 58). Deleterious mutation. No detectable ALDP in patient cells (53, 58).
153006119 c.1726dup p.Leu576Profs*25 exon 7 Pathogenic, identified in ALD patient (120). Deleterious mutation.
153006120 c.1727T>C p.Leu576Pro exon 7 Pathogenic, identified in 4 ALD patients (93, 98, 132, 137).
153006122 c.1729G>T p.Glu577* exon 7 Pathogenic, identified in ALD patient (100). Deleterious mutation.
153006124 c.1731del p.Ala578Profs*58 exon 7 Pathogenic, identified in ALD patient (105). Deleterious mutation.
153006125 c.1732G>A p.Ala578Thr exon 7 VUS (X:153006125 G/A) frequency 6/178388 control alleles.
153006127 c.1734C>G p.Ala578Ala exon 7 Synonymous (X:153006127 C/G).
153006136 c.1743C>T p.Asp581Asp exon 7 Synonymous (X:153006136 C/T).
153006137 c.1744G>A p.Val582Ile exon 7 Benign, based on its frequency of 2122/81726 control alleles (X:153006137 G/A).
153006137 c.1744G>T p.Val582Phe exon 7 VUS (X:153006137 G/T).
153006139 c.1746del p.Val583Cysfs*53 exon 7 Pathogenic, identified in 2 ALD patients (27, 158). Deleterious mutation.
153006140 c.1747_1759del p.Val583Thrfs*49 exon 7 Pathogenic, identified in ALD patient (145). Deleterious mutation.
153006141 c.1748T>A p.Val583Glu exon 7 Benign, based on its frequency of 2132/81068 control alleles (X:153006141 T/A).
153006141 c.1748T>C p.Val583Ala exon 7 Benign, based on its frequency of 26/169917 control alleles (X:153006141 T/C).
153006141 c.1748T>G p.Val583Gly exon 7 Pathogenic, identified in ALD patient (33).
153006143 c.1750C>T p.His584Tyr exon 7 VUS (X:153006143 C/T) frequency 1/178270 control alleles
153006147 c.1754T>C p.Leu585Pro exon 7 Pathogenic, identified in ALD patient (68).
153006148 c.1755del p.His586Thrfs*50 exon 7 Pathogenic, identified in ALD patient (62). Deleterious mutation.
153006152 c.1759_61dup p.His587dup exon 7 Pathogenic, identified in ALD patient (125).
153006152 c.1759_70del12 p.His587_Gln590del exon 7 Pathogenic, identified in ALD patient (24).
153006158 c.1765del p.Leu589Cysfs*47 exon 7 Pathogenic, identified in ALD patient (49). Deleterious mutation.
153006161 c.1768C>T p.Gln590* exon 7 Pathogenic, identified in 8 ALD patients (20, 88, 176). Deleterious mutation.
153006162 c.1769A>T p.Gln590Leu exon 7 VUS (X:153006162 A/T) frequency 2/178017 control alleles.
153006164 c.1771del p.Arg591Glyfs*45 exon 7 Pathogenic, identified in ALD patient (33). Deleterious mutation.
153006164 c.1771C>T p.Arg591Trp exon 7 Pathogenic, identified in 8 ALD patients (24, 32, 33, 53, 72, 161). Normal ALDP level in patient cells (53), but non-functional.
153006165 c.1772G>T p.Arg591Leu exon 7 Pathogenic, identified in 3 ALD patients (88, 145).
153006165 c.1772G>C p.Arg591Pro exon 7 Pathogenic, identified in 3 ALD patients (44, 49, 105). No detectable ALDP expression in patient cells (49).
153006165 c.1772G>A p.Arg591Gln exon 7 Pathogenic, identified in 17 ALD patients (22, 32, 33, 78, 98, 108, 145, 175). Normal ALDP level in patient cells (22, 33), but non-functional (33).
153006173 c.1780G>C p.Gly594Arg exon 7 Pathogenic, identified in 2 ALD patients (33, 83).
153006174 c.1780+1G>A p.Trp595fs*? IVS 7 Pathogenic, identified in 2 ALD patients (7, 53). Deleterious mutation.
153006175 c.1780+2T>G p.Trp595fs*? IVS 7 Pathogenic, identified in 8 ALD patients (33, 38, 58, 71, 118, 150, 158). No detectable ALDP in patient cells (58) due to splicing defect (118).
153006177 c.1780+4G>A IVS 7 Benign, based on its frequency of 41/199340 control alleles (X:153006177 G/A).
153008436 c.1781-5C>G IVS 7 Benign, based on its frequency of 12/165244 control alleles (X:153008436 C/G).
153008439 c.1781-2A>G p.Trp595fs*? IVS 7 Pathogenic, identified in 3 ALD patients (32, 33). Deleterious mutation. No detectable ALDP in patient cells (32).
153008440 c.1781-1G>A p.Trp595fs*? IVS 7 Pathogenic, identified in ALD patient (96). Deleterious mutation.
153008440 c.1781-1G>T p.Trp595fs*? IVS 7 Pathogenic, identified in ALD patient (33). Deleterious mutation.
153008443 c.1783T>C p.Trp595Arg exon 8 Pathogenic, identified in ALD patient (88).
153008444 c.1784G>A p.Trp595* exon 8 Pathogenic, identified in 2 ALD patients (33, 90). Deleterious mutation.
153008445 c.1785G>A p.Trp595* exon 8 Pathogenic, identified in 4 ALD patients (24, 59, 64, 132). Deleterious mutation.
153008450 c.1790C>G p.Ala597Gly exon 8 Reported in ExAC (X:153008450 C/G) as a VUS. Pathogenic, identified in ALD patient (58). No detectable ALDP in patient cells (58).
153008451 c.1791_92del p.Met598Valfs*2 exon 8 Pathogenic, identified in ALD patient (6). Deleterious mutation. No detectable ALDP in patient cells (58).
153008452 c.1792A>G p.Met598Val exon 8 VUS (X:153008452 A/G) frequency 7/174488 control alleles.
153008454 c.1794G>T p.Met598Ile exon 8 VUS (X:153008454 G/T).
153008462 c.1802G>A p.Trp601* exon 8 Pathogenic, identified in 9 ALD patients (27, 33, 53, 79, 100, 154). Deleterious mutation. No detectable ALDP in patient cells (53).
153008463 c.1803G>A p.Trp601* exon 8 Pathogenic, identified in 3 ALD patients (33, 77, 88). Deleterious mutation.
153008464 c.1804A>T p.Lys602* exon 8 Pathogenic, identified in ALD patient (93). Deleterious mutation.
153008470 c.1810G>A p.Val604Ile exon 8 Benign, based on its frequency of 111/179305 control alleles (X:153008470 G/A).
153008474 c.1814T>A p.Leu605Gln exon 8 Pathogenic, identified in 4 ALD patients (59, 64, 132, 137).
153008474 c.1814T>C p.Leu605Pro exon 8 Pathogenic, identified in ALD patient (33).
153008475 c.1815G>C p.Leu605Leu exon 8 Synonymous (X:153008475 G/C).
153008476 c.1816T>C p.Ser606Pro exon 8 Pathogenic, identified in 7 ALD patients (7, 33, 71, 72, 96, 100, 150). No detectable ALDP in patient cells (72).
153008476 c.1816T>G p.Ser606Ala exon 8 Pathogenic, identified in ALD patient (32).
153008477 c.1817C>T p.Ser606Leu exon 8 Pathogenic, identified in 28 ALD patients (6, 13, 22, 24, 33, 46, 49, 52, 57, 58, 59, 60, 64, 97, 100, 132, 137, 178, 180). Reduced (25% of control cells) ALDP in patient cells (97) using a quantitative immunoblot technique, detectable ALDP by immunofluorescence (22, 33, 49, 60).
153008478 c.1818G>A p.Ser606Ser exon 8 Synonymous (X:153008478 G/A).
153008478 c.1818G>C p.Ser606Ser exon 8 Synonymous (X:153008478 G/C).
153008480 c.1820del p.Gly607Valfs*29 exon 8 Pathogenic, identified in ALD patient (6). Deleterious mutation. No detectable ALDP in patient cells (6).
153008480 c.1820_23del p.Gly607Alafs*28 exon 8 Pathogenic, identified in ALD patient (33). Deleterious mutation.
153008480 c.1820G>A p.Gly607Asp exon 8 Pathogenic, identified in ALD patient (52, 58). Normal ALDP level in patient cells (58), but non-functional.
153008482 c.1822G>A p.Gly608Ser exon 8 Pathogenic, identified in 3 ALD patients (58, 62, 105).
153008483 c.1823G>A p.Gly608Asp exon 8 Reported in ALD male (48), but considering its frequency of 306/36626 control alleles (X:153008483 G/A) this is not a pathogenic variant.
153008485 c.1825G>A p.Glu609Lys exon 8 Pathogenic, identified in 29 ALD patients (15, 16, 32, 33, 49, 60, 62, 72, 88, 90, 97, 141, 146). Reduced (2% of control cells) ALDP in patient cells (97) using a quantitative immunoblot technique, no detectable ALDP by immunofluorescence (32, 49, 60, 72, 141, 146).
153008486 c.1826A>G p.Glu609Gly exon 8 Pathogenic, identified in 3 ALD patients (16, 97, 141). Reduced (2% of control cells) ALDP in patient cells (97) using a quantitative immunoblot technique, no detectable ALDP by immunofluorescence (32, 49, 60, 72, 141, 146).
153008492 c.1832A>G p.Gln611Arg exon 8 Pathogenic, identified in ALD patient (33).
153008493 c.1833G>C p.Gln611His exon 8 Pathogenic, identified in ALD patient (33).
153008498 c.1838T>A p.Ile613Asn exon 8 Pathogenic, identified in ALD patient (33).
153008499 c.1839C>T p.Ile613Ile exon 8 Synonymous (X:153008499 C/T).
153008500 c.1840G>A p.Gly614Ser exon 8 VUS (X:153008500 G/A) frequency 3/21806 control alleles.
153008500 c.1840G>C p.Gly614Arg exon 8 Pathogenic, identified in ALD patient (88).
153008506 c.1846G>A p.Ala616Thr exon 8 Pathogenic, identified in 8 ALD patients (32, 97, 141). Reduced (4% of control cells) ALDP in patient cells (97) using a quantitative immunoblot technique, no detectable ALDP by immunofluorescence (32, 141).
153008507 c.1847C>A p.Ala616Asp exon 8 Pathogenic, identified in ALD patient (90).
153008507 c.1847C>T p.Ala616Val exon 8 Pathogenic, identified in ALD patient (29).
153008509 c.1849C>A p.Arg617Ser exon 8 Pathogenic, identified in ALD patient (92).
153008509 c.1849C>G p.Arg617Gly exon 8 Pathogenic, identified in 10 ALD patients (15, 33, 59, 64, 67, 86, 93, 132, 137).
153008509 c.1849C>T p.Arg617Cys exon 8 Pathogenic, identified in 30 ALD patients (6, 15, 16, 32, 33, 49, 58, 59, 60, 64, 86, 88, 93, 132, 137, 145, 178). No detectable ALDP in patient cells (32, 49, 58).
153008509 c.1849del p.Arg617Alafs*19 exon 8 Pathogenic, identified in ALD patient (60). Deleterious mutation. No detectable ALDP in patient cells (60).
153008510 c.1850del p.Arg617Profs*19 exon 8 Pathogenic, identified in ALD patient (33). Deleterious mutation.
153008510 c.1850G>A p.Arg617His exon 8 Pathogenic, identified in 46 ALD patients (6, 13, 17, 22, 32, 33, 49, 57, 58, 60, 62, 74, 87, 88, 96, 100, 125, 145, 147, 154, 178). No detectable ALDP in patient cells (22, 33, 49, 58, 60, 147).
153008518 c.1858T>C p.Tyr620His exon 8 Pathogenic, identified in 2 ALD patients (88, 99).
153008519 c.1859del p.Tyr620Serfs*16 exon 8 Pathogenic, identified in 2 ALD patients (80). Deleterious mutation.
153008519 c.1859A>G p.Tyr620Cys exon 8 Pathogenic, identified in ALD patient (58). No detectable ALDP in patient cells (58).
153008520 c.1860C>G p.Tyr620* exon 8 Pathogenic, identified in ALD patient (58). Deleterious mutation.
153008522 c.1862dup p.His621Glnfs*10 exon 8 Pathogenic, identified in ALD patient (58). Deleterious mutation.
153008526 c.1865+1G>A p.Pro623fs*? IVS 8 Pathogenic, identified in 2 ALD patients (33, 152). Reduced (<1% of control cells) ALDP in patient cells due to splicing defect (152).
153008660 c.1866-15G>A p.Pro623fs*? IVS 8 Pathogenic, identified in 3 ALD patients (32).
153008665 c.1866-10G>A p.Pro623fs*? IVS 8 Pathogenic, identified in 23 ALD patients (11, 30, 32, 33, 58, 72, 100, 125, 145, 156, 178). No detectable ALDP in patient cells (32, 58, 72) due to splicing defect (11, 30).
153008670 c.1866-5C>T IVS 8 VUS (X:153008670 C/T).
153008673 c.1866-2A>T p.Pro623fs*? IVS 8 Pathogenic, identified in 4 ALD patients (32). No detectable ALDP in patient cells (32) due to splicing defect.
153008677 c.1868C>T p.Pro623Leu exon 9 Pathogenic, identified in ALD patient (100).
153008679 c.1870A>G p.Lys624Glu exon 9 VUS (X:153008679 A/G) frequency 1/169754 control alleles.
153008685 c.1876G>A p.Ala626Thr exon 9 Pathogenic, identified in 12 ALD patients (22, 33, 49, 145). No detectable ALDP in patient cells (22, 33, 49).
153008685 c.[1876G>A; 2087A>T] p.[Ala626Thr; Lys696Met] exon 9 + exon 10 Pathogenic, identified in ALD patient (32). p.Ala626Thr is pathogenic; p.Lys696Met is a VUS (X:153009038 A/T).
153008686 c.1877C>A p.Ala626Asp exon 9 Pathogenic, identified in ALD patient (49).
153008689 c.1880T>A p.Leu627His exon 9 Pathogenic, identified in ALD patient (32).
153008689 c.1880dup p.Leu628Profs*3 exon 9 Pathogenic, identified in ALD patient (58). Deleterious mutation.
153008690 c.1881C>T p.Leu627Leu exon 9 Synonymous (X:153008690 C/T).
153008692 c.1883T>A p.Leu628Gln exon 9 Pathogenic, identified in ALD patient (100).
153008692 c.1883T>C p.Leu628Pro exon 9 Pathogenic, identified in 3 ALD patients (33, 60). No detectable ALDP in patient cells (60).
153008694 c.1885G>A p.Asp629Asn exon 9 Pathogenic, identified in 2 ALD patients (145, 165).
153008694 c.1885G>C p.Asp629His exon 9 Pathogenic, identified in ALD patient (22). Normal ALDP level in patient cells (22), but non-functional.
153008697 c.1888G>A p.Glu630Lys exon 9 Pathogenic, identified in 2 ALD patients (33, 145).
153008698 c.1889A>G p.Glu630Gly exon 9 Pathogenic, identified in ALD patient (49).
153008700 c.1891T>C p.Cys631Arg exon 9 Pathogenic, identified in 4 ALD patients (32, 33, 60). No detectable ALDP in patient cells (60).
153008701 c.1892G>A p.Cys631Tyr exon 9 Pathogenic, identified in 5 ALD patients (33, 49, 76, 93).
153008702 c.1893C>G p.Cys631Trp exon 9 Pathogenic, identified in ALD patient (33).
153008703 c.1894A>C p.Thr632Pro exon 9 Pathogenic, identified in 5 ALD patients (33, 96, 100, 120).
153008704 c.1895C>T p.Thr632Ile exon 9 Pathogenic, identified in 11 ALD patients (33, 49, 147), confirmed by extensive pedigree analysis (147).
153008707 c.1898G>T p.Ser633Ile exon 9 Pathogenic, identified in ALD patient (48).
153008708 c.1899C>T p.Ser633Ser exon 9 Synonymous (X:153008708 C/T).
153008708 c.1899delC p.Ser633Argfs*3 exon 9 Pathogenic, identified in 4 ALD patients (32, 141). Deleterious mutation. No detectable ALDP in patient cells (141).
153008708 c.1899C>A p.Ser633Arg exon 9 Pathogenic, identified in 2 ALD patients (29, 96).
153008709 c.1900G>T p.Ala634Ser exon 9 VUS (X:153008709 G/T).
153008709 c.1900G>A p.Ala634Thr exon 9 Pathogenic, identified in ALD patient (32).
153008711 c.1902C>T p.Ala634Ala exon 9 Synonymous (X:153008711 C/T).
153008712 c.1903G>A p.Val635Met exon 9 Pathogenic, identified in 3 ALD patients (32, 49, 58). Affects ALDP stability in patient cells (32, 58).
153008712 c.1903_04insCCA p.Val635delinsAlaMet exon 9 Pathogenic, identified in 2 ALD patients (72, 145). Affects ALDP stability in patient cells (72).
153008715 c.1906delA p.Ser636Alafs*55 exon 9 Pathogenic, identified in ALD patient (33). Deleterious mutation.
153008716 c.1907_25del p.Ser636Argfs*49 exon 9 Pathogenic, identified in 3 ALD patients (32). Deleterious mutation.
153008716 c.1907G>T p.Ser636Ile exon 9 Pathogenic, identified in 2 ALD patients (27, 42). No detectable ALDP in patient cells (42).
153008718 c.1909A>G p.Ile637Val exon 9 VUS (X:153008718 A/G).
153008720 c.1911C>T p.Ile637Ile exon 9 Synonymous (X:153008720 C/T).
153008721 c.1912G>T p.Asp638Tyr exon 9 Pathogenic, identified in 3 ALD patients (38).
153008723 c.1914C>T p.Asp638Asp exon 9 Synonymous (X:153008723 C/T).
153008724 c.1915G>A p.Val639Met exon 9 VUS (X:153008724 G/A).
153008727 c.1918G>A p.Glu640Lys exon 9 Pathogenic, identified in 4 ALD patients (33, 96).
153008735 c.1926_27insCAAG p.Ile643Glnfs*92 exon 9 Pathogenic, identified in ALD patient (32). Deleterious mutation.
153008742 c.1933C>T p.Gln645* exon 9 Pathogenic, identified in 3 ALD patients (22, 33). Deleterious mutation. No detectable ALDP in patient cells (22, 33).
153008745 c.1936G>C p.Ala646Pro exon 9 Pathogenic, identified in 2 ALD patients (29, 33).
153008748 c.1939_40insGG p.Ala647Glyfs*45 exon 9 Pathogenic, identified in 4 ALD patients (71, 72). Deleterious mutation. No detectable ALDP in patient cells (72).
153008751 c.1942A>T p.Lys648* exon 9 Pathogenic, identified in ALD patient (84). Deleterious mutation.
153008757 c.1948_49del p.Ala650Glyfs*83 exon 9 Pathogenic, identified in ALD patient (7). Deleterious mutation. No detectable ALDP in patient cells (7).
153008759 c.1950G>A p.Ala650Ala exon 9 Synonymous (X:153008759 G/A).
153008770 c.1961T>G p.Leu654Arg exon 9 Pathogenic, identified in ALD patient (33).
153008770 c.1961T>C p.Leu654Pro exon 9 Pathogenic, identified in 19 ALD patients (32, 49, 62, 97, 139, 141). Reduced (2% of control cells) ALDP in patient cells (97) using a quantitative immunoblot technique, no detectable ALDP by immunofluorescence (32, 49, 139, 141).
153008773 c.1964T>C p.Leu655Pro exon 9 Pathogenic, identified in ALD patient (53). Affects ALDP stability in patient cells (53).
153008776 c.1967C>T p.Ser656Phe exon 9 Pathogenic, identified in ALD patient (33).
153008779 c.1970_72del p.Ile657del exon 9 Pathogenic, identified in 12 ALD patients (16, 32, 33, 111, 141, 185). No detectable ALDP in patient cells (32, 141).
153008782 c.1973C>T p.Thr658Ile exon 9 Pathogenic, identified in 2 ALD patients (33, 58). No detectable ALDP in patient cells (58).
153008787 c.1978C>T p.Arg660Trp exon 9 Pathogenic, identified in 41 ALD patients (7, 13, 16, 22, 23, 24, 32, 33, 49, 53, 57, 58, 60, 88, 90, 97, 135, 141, 145, 146). Reduced (2% of control cells) ALDP in patient cells (97) using a quantitative immunoblot technique, no detectable ALDP by immunofluorescence (7, 22, 23, 32, 33, 49, 53, 58, 141, 146).
153008788 c.1979G>A p.Arg660Gln exon 9 Pathogenic, identified in 5 ALD patients (71, 72, 150). No detectable ALDP in patient cells (72).
153008788 c.1979G>C p.Arg660Pro exon 9 Pathogenic, identified in ALD patient (48).
153008791 c.1982_83del p.Pro661Leufs*72 exon 9 Pathogenic, identified in 2 ALD patients (32). Deleterious mutation.
153008797 c.1988T>A p.Leu663Gln exon 9 Pathogenic, identified in 2 ALD patients (32, 58). Affects ALDP stability in patient cells (32, 58).
153008797 c.1988_89insT p.Trp664Valfs*70 exon 9 Pathogenic, identified in 2 ALD patients (33, 49). Deleterious mutation. No detectable ALDP in patient cells (33).
153008801 c.1991+1G>A p.Lys665fs*? IVS 9 Pathogenic, identified in ALD patient (49). Deleterious mutation.
153008802 c.1991+2T>C p.Lys665fs*? IVS 9 Pathogenic, identified in ALD patient (33). Deleterious mutation.
153008805 c.1991+5G>T IVS 9 VUS (X:153008805 G/T).
153008807 c.1991+7G>A IVS 9 VUS (X:153008807 G/A) frequency 5/130456 control alleles.
153008941 c.1992-2A>G p.Lys665fs*? IVS 9 Pathogenic, identified in 2 ALD patients (32). Deleterious mutation.
153008942 c.1992-1G>A p.Lys665fs*? IVS 9 Pathogenic, identified in ALD patient (49). Deleterious mutation.
153008943 c.1992G>A p.Trp664* exon 10 Pathogenic, identified in ALD patient (98). Deleterious mutation.
153008944 c.1993_95delinsGAG p.Lys665delinsGlu exon 10 Pathogenic, identified in ALD patient (72). Affects ALDP stability in patient cells (72).
153008945 c.1994A>C p.Lys665Thr exon 10 VUS (X:153008945 A/C) frequency 1/165162 control alleles.
153008948 c.[1997A>C;2007C>G] p.[Tyr666Ser;His669Gln] exon 10 Pathogenic, identified in ALD patient (62). Unclear which of the two variants is pathogenic.
153008949 c.1998C>G p.Tyr666* exon 10 Pathogenic, identified in ALD patient (33). Deleterious mutation.
153008950 c.1999C>G p.His667Asp exon 10 Pathogenic, identified in 4 ALD patients (49, 62, 90, 97). Reduced (3% of control cells) ALDP in patient cells (97) using a quantitative immunoblot technique, no detectable ALDP by immunofluorescence (49).
153008950 c.1999_2000delCA p.His669Leufs*64 exon 10 Pathogenic, identified in ALD patient (29). Deleterious mutation.
153008951 c.2000A>G p.His667Arg exon 10 Pathogenic, identified in ALD patient (33).
153008951 c.2000A>T p.His667Leu exon 10 Pathogenic, identified in ALD patient (53). Affects ALDP stability in patient cells (53).
153008953 c.2002A>C p.Thr668Pro exon 10 Pathogenic, identified in ALD patient (33).
153008954 c.2003C>T p.Thr668Ile exon 10 Pathogenic, identified in 2 ALD patients (33, 49). No detectable ALDP in patient cells (49).
153008957 c.2006_07del p.His669Leufs*64 exon 10 Pathogenic, identified in ALD patient (33). Deleterious mutation.
153008957 c.2006A>G p.His669Arg exon 10 Pathogenic, identified in 7 ALD patients (33, 58, 104, 135, 145). No detectable ALDP in patient cells (58).
153008958 c.[2007C>G;1997A>C] p.[His669Gln;Tyr666Ser] exon 10 Pathogenic, identified in ALD patient (62). Unclear which of the two variants is pathogenic.
153008961 c.2010_11insT p.Leu671Serfs*63 exon 10 Pathogenic, identified in ALD patient (33). Deleterious mutation.
153008961 c.2010_2014delinsTAT p.Leu670Phefs*63 exon 10 Pathogenic, identified in 3 ALD patients (87). Deleterious mutation.
153008961 c.2010dupG p.Leu671Alafs*63 exon 10 Pathogenic, identified in ALD patient (181). Deleterious mutation.
153008965 c.2014C>T p.Gln672* exon 10 Pathogenic, identified in 6 ALD patients (25, 27, 28, 33, 87, 88). Deleterious mutation. No detectable ALDP in patient cells (25).
153008970 c.2019C>T p.Phe673Phe exon 10 Synonymous (X:153008970 C/T).
153008970 c.2019C>G p.Phe673Leu exon 10 VUS (X:153008970 C/G) frequency 2/164208 control alleles.
153008971 c.2020G>A p.Asp674Asn exon 10 VUS (X:153008971 G/A) frequency 1/21495 control alleles.
153008977 c.2026G>T p.Glu676* exon 10 Pathogenic, identified in 2 ALD patients (33). Deleterious mutation.
153008981 c.2030G>A p.Gly677Asp exon 10 Pathogenic, identified in ALD patient (96).
153008982 c.2031C>T p.Gly677Gly exon 10 Synonymous (X:153008982 C/T).
153008983 c.2032G>A p.Gly678Ser exon 10 VUS (X:153008983 G/A) frequency 1/21526 control alleles.
153008984 c.2033G>A p.Gly678Asp exon 10 VUS (X:153008984 G/A).
153008986 c.2035T>C p.Trp679Arg exon 10 Pathogenic, identified in 3 ALD patients (14, 88).
153008987 c.2036G>A p.Trp679* exon 10 Pathogenic, identified in ALD patient (84). Deleterious mutation.
153008988 c.2037G>A p.Trp679* exon 10 Pathogenic, identified in 6 ALD patients (32, 33, 100, 154). Deleterious mutation.
153008994 c.2043C>T p.Phe681Phe exon 10 Synonymous (X:153008994 C/T).
153008994 c.2043C>G p.Phe681Leu exon 10 Benign, based on its frequency of 26/181918 control alleles (X:153008994 C/G).
153008995 c.2044G>C p.Glu682Gln exon 10 Benign, based on its frequency of 13/181548 control alleles (X:153008995 G/C).
153009002 c.2051T>C p.Leu684Pro exon 10 Pathogenic, identified in ALD patient (33).
153009012 c.2061_2200del p.Leu690Profs*65 exon 10 Pathogenic, identified in ALD patient (32). Deleterious mutation.
153009016 c.2065C>T p.Arg689Cys exon 10 Benign, based on its frequency of 12/176163 control alleles (X:153009016 C/T).
153009024 c.2073C>G p.Ser691Arg exon 10 VUS (X:153009024 C/G).
153009029 c.2078C>T p.Thr693Met exon 10 Pathogenic, identified in ALD patient (49). Normal ALDP level in patient cells (49), but non-functional.
153009038 c.2087A>T p.Lys696Met exon 10 VUS (X:153009038 A/T) frequency 8/151181 control alleles.
153009041 c.2090A>G p.Gln697Arg exon 10 VUS (X:153009041 A/G) frequency 3/147671 control alleles.
153009062 c.2111C>T p.Ala704Val exon 10 VUS (X:153009062 C/T).
153009063 c.2112G>A p.Ala704Ala exon 10 Synonymous (X:153009063 G/A).
153009074 c.2123A>G p.Lys708Arg exon 10 VUS (X:153009074 A/G) frequency 1/21422 control alleles.
153009078 c.2127G>A p.Met709Ile exon 10 VUS (X:153009078 G/A) frequency 2/136452 control alleles.
153009082 c.2131C>T p.Arg711Trp exon 10 VUS (X:153009082 C/T).
153009083 c.2132G>A p.Arg711Gln exon 10 VUS (X:153009083 G/A) frequency 3/132083 control alleles.
153009089 c.2138T>C p.Leu713Pro exon 10 VUS (X:153009089 T/C) frequency 1/130825 control alleles.
153009094 c.2143G>A p.Glu715Lys exon 10 VUS (X:153009094 G/A) frequency 1/21236 control alleles.
153009109 c.2158C>G p.Leu720Val exon 10 VUS (X:153009109 C/G).
153009124 c.2173G>A p.Ala725Thr exon 10 VUS (X:153009124 G/A) frequency 4/114962 control alleles.
153009136 c.2185G>A p.Val729Met exon 10 VUS (X:153009136 G/A) frequency 1/111788 control alleles.
153009140 c.2189C>T p.Pro730Leu exon 10 VUS (X:153009140 C/T) frequency 4/130292 control alleles.
153009141 c.2190G>A p.Pro730Pro exon 10 Synonymous (X:153009141 G/A).
153009152 c.2201C>G p.Pro734Arg exon 10 VUS (X:153009152 C/G) frequency 3/127737 control alleles.
153009152 c.2201C>T p.Pro734Leu exon 10 VUS (X:153009152 C/T) frequency 9/127737 control alleles.
153009153 c.2202G>A p.Pro734Pro exon 10 Synonymous (X:153009153 G/A).
153009160 c.2209C>T p.Pro737Ser exon 10 VUS (X:153009160 C/T) frequency 1/20978 control alleles.
153009173 c.2222A>G p.Gln741Arg exon 10 VUS (X:153009173 A/G).
153009176 c.2225G>T p.Gly742Val exon 10 VUS (X:153009176 G/T).
153009184 c.2233A>C p.Thr745Pro exon 10 VUS (X:153009184 A/C).
153009190 c.2238*1C>T 3′ UTR VUS (X:153009190 C/T).
153009196 c.2238*7C>T 3′ UTR VUS (X:153009196 C/T).
153009197 c.2238*8G>C 3′ UTR Benign, based on its frequency of 81685/120445 control alleles (X:153009197 G/C).

Legend: Mutations are arranged according to their nucleotide position. All mutations (including those that have been published in the past) are annotated using Alamut software using transcript NM_000033.3 on GRCh37 (hg19) as reference sequence. The number of clinically/biochemically affected ALD patients that have been reported/identified for each mutation is indicated. In case additional experimental proof with respect to the effect of the mutation on the ALD protein (ALDP) or mRNA splicing is available references are provided. Note: unpublished mutations (unpublished data) may not be used for publication purposes without prior approval from the editor of the database and the laboratories/investigators that have identified these mutations.
Because ABCD1 mutations have no predictive value with respect to the clinical outcome of an individual patient no phenotypic information is provided.

Back to information

References

1 Barcelo et al. Hum Mol Genet 1994;3(10):1889-90
2 Barcelo et al. Hum Mutat 1996;8(3):286-7
3 Berger et al. Biochem Biophys Res Commun 1994;205(3):1638-43
4 Braun et al. Am J Hum Genet 1995;56(4):854-61
5 Cartier et al. Hum Mol Genet 1993;2(11):1949-51
6 Fanen et al. J Clin Invest 1994;94(2):516-20
7 Feigenbaum et al. Am J Hum Genet 1996;58(6):1135-44
8 Fuchs et al. Hum Mol Genet 1994;3(10):1903-5
9 Imamura et al. Clin Genet 1997;51(5):322-5
10 Kemp et al. Biochem Biophys Res Commun 1994;202(2):647-53
11 Kemp et al. Hum Mutat 1995;6(3):272-3
12 Koike et al. Hum Mutat 1995;6(3):263-7
13 Kok et al. Hum Mutat 1995;6(2):104-15
14 Korenke et al. Hum Mutat 1998;Suppl 1:S204-6
15 Krasemann et al. Hum Genet 1996;97(2):194-7
16 Ligtenberg et al. Am J Hum Genet 1995;56(1):44-50
17 Matsumoto et al. Jpn J Hum Genet 1994;39(3):345-51
18 Mosser et al. Nature 1993;361(6414):726-30
19 Song et al. Hum Mol Genet 1995;4(6):1093-4
20 Uchiyama et al. Biochem Biophys Res Commun 1994;198(2):632-6
21 Ueyema et al. Jpn J Hum Genet 1996;41(4):407-11
22 Watkins et al. Am J Hum Genet 1995;57(2):292-301
23 Yasutake et al. J Neurol Sci 1995;131(1):58-64
24 Takano et al. Arch Neurol 1999;56(3):295-300
25 Holzinger et al. Clin Genet 1998;53(6):482-7
26 Osaka et al. J Inherit Metab Dis 1998;21(2):162-6
27 Gartner et al. Neuropediatrics 1998;29(1):3-13
28 Smith et al. Neurochem Res 1999;24(4):521-35
29 Lachtermacher et al. Hum Mutat 15:348-53
30 Yanagawa et al. Kobe J Med Sci 1998;44(1):9-17
31 Kano et al. J Neurol Sci 1998;158(2):187-92
32 Laboratory Genetic Metabolic Diseases, Academic Medical Center, Amsterdam, The Netherlands. Contact person: Dr. H.R. Waterham (e-mail: h.r.waterham@amc.uva.nl). Unpublished data
33 The Johns Hopkins DNA Diagnostic Lab, Institute of Genetic Medicine, Baltimore, MD, USA. Contact person: Dr. S.J.S. Steinberg (e-mail: S.J.Steinberg@jhmi.edu). Unpublished data
34 Perusi et al. Mol Cell Probes 1999;13(3):179-82
35 Dunne et al. Ann Neurol 1999;45(5):652-5
36 Maier et al. Prenat Diagn 1999;19(4):364-8
37 Gomez-Lira et al. J Neurol Sci 1999;165(1):62-65.
38 Wichers et al. Hum Genet 1999;105:116-9.
40 Gomez Lira et al. Hum Mutat 2000;16(3):271.
41 Ohi et al., J Neurol Sci 2000 177:131-38
42 Berger et al. (2000) Hum Mutat, Mutation and Polymorphism Report #188 Online
43 De Meirleir et al. (2000) J Inherit Metab Dis 23 (Suppl 1):251
44 Tang et al. (2000) J Inherit Metab Dis 23 (Suppl 1):251
45 O.Neill et al. (2001) Neurology 57(11):1956-62
46 Korenke et al. (1996) Ann Neurol 40: 254
47 Neumann et al. (2001) Genet Test 5:65-8
48 Dvoráková et al. (2001) Hum Mutat 18(1):52-60
49 Kemp et al. (2001) Hum Mutat 18(6):499-515
50 Institut fuer Humangenetik und Medizinische Biologie, Magdeburgerstr. 2, 06097 Halle/Saale, Germany. Contact person: Dr. Hannelore Thiel (e-mail: hannelore.thiele@medizin.uni-halle.de). Unpublished data
51 Vorgerd et al. (1998) Nervenartz 69(2):174-9
52 Medical Genetic Research Center , Depart. of Inherited Metabolic Diseases, Moskvorechie str 1, Russian Academy of Medical Sciences , Moscow, Russia. Contact persons: Drs. E. Voskoboeva and E. Lomonosova. e-mail: sigorag@orc.ru). Unpublished data
53 Guimaraes et al. (2002) Mol Genet Metab 76(1):62-7
54 Department of Pediatrics, First Hospital, Peking University, Beijing, P.R. China. Xiong Hui, Pan Hong, Zhang Yuehua & Wu Xiru. Contact person: Pan Hong (e-mail: panmuren@263.net). Unpublished data
55 Lan et al. (2001) Clin Chem Lab Med 39(12):1190-4
56 Research Center for Molecular Diagnosis of Genetic Diseases, Fuzhou General Hospital, Fujian Medical University 350025, China. Contact person: Fenghua Lan (e-mail: fhlan@mail.fjmu.edu.cn). Unpublished data
57 Matsumoto et al. (2003) J Hum Genet 48(3):125-9
58 Pitié-Salpétrière Hospital (Biochemistry Department) and Hôpital Saint-Vincent de Paul (Service Pédiatrie C, Inserm U561) Paris, France. Contact persons: Prof. Bernard Hainque (e-mail: bernard.hainque@psl.ap-hop-paris.fr) and Prof. Patrick Aubourg (e-mail: patrick.aubourg@inserm.fr) Unpublished data
59 Pan et al. (2004) Zhonghua Yi Xue Yi Chuan Xue Za Zhi 21(1):1-4
60 Coll et al. (2005) Clin Genet. 67(5):418-24
61 Mak et al. (2005) Horm Res. 63(1):1-5.
62 Asheuer et al. (2005) Hum Mol Genet. 14(10):1293-303
63 Montagna et al. (2005) Hum Mut. 25(2):222
64 Pan et al. (2005) Pediatr Neurol. 33(2):114-120.
65 Mukherjee et al. (2006) J. R. Soc Med. 99:245-249
66 Dvoráková et al. (2007) Hum Genet. 121(2):288.
67 Huang et al. (2004) Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 21(3):193-7.
68 Chiu et al. (2006) Pediatr Neurol 35(4):250-6
69 Liu et al. (2007) Pediatr Neurol 36:348-50
70 Sutovsky et al. (2007) J Neurol Sci 263(1-2):149-53
71 Shukla et al. (2011) Clin Chim Acta 412(23-24):2289-95
72 Kumar et al. (2011) PLoS One 6(9):e25094
73 Vachalova et al. (2007) Bratisl Lek Listy 108(10-11):462-6.
74 Fogel et al. (2008) Neurogenetics 9(3):215-8.
75 Kumar et al. (2008) Pediatric Neurology 39(4):289-92
76 Wang et al. (2008) Clin Chem Lab Med 46(12):1702-6
77 Bonilla Guerrero et al., (2008) J Inherit Metab Dis 31 Suppl 2:S453-6
78 Costello et al. (2009) N Engl J Med 360(2):171-81.
79 Dohle et al. (2009) J Neurol Sci 285(1-2):235-7.
80 Li et al. (2010) J Neurol Sci 290(1-2):163-5.
81 Amorosi et al. (2010) Hum Genet. 127(4):486.
83 Gosalakkal & Balky (2010) Neurol India 58(1):109-11
84 Centro de Genética Médica Dr. Jacinto Magalhães (Medical Genetics Center of the National Institute of Health), Porto, Portugal. Contact person: Francisco E. R. Laranjeira (e-mail: francisco.laranjeira@insa.min-saude.pt). Unpublished data
85 Di Filippo et al. (2010) J Neurol 258(2):323-4.
86 Lan et al. (2010) Clin Chim Acta 412(11-12):970-4.
87 Miyoshi et al. (2010) Endocr J 57(11):965-72
88 Shimozawa et al. (2010) J Hum Genet 56(2):106-9.
89 Xie et al. (2010) Zhonghua Yi Xue Yi Chuan Xue Za Zhi 27(2):144-8.
90 Matsukawa et al. (2010) Neurogenetics 12(1):41-50
91 Valadares et al. (2011) Genet Mol Res 10(1):65-74
92 Kumar et al. (2010) J Genet 89(4):473-7.
93 Lan et al. (2011) Clin Chim Acta 412(11-12):970-4.
94 Soardi et al. (2010) Arq Bras Endocrinol Metabol 54(8):738-43.
95 Center of Medical Genetics, Sir Ganga Ram Hospital, Rajinder Nagar, New Delhi, India – 110060. Dr I.C. Verma, Dr R. Saxena , Dr S. Kohli & Dr S. Bijarnia. Contact person: Dr. Renu Saxena (e-mail: renu2006@gmail.com). Unpublished data
96 Wang et al. (2011) Mol Genet Metab 104(1-2):160-6.
97 Zhang et al. (2011) Biochem J 436(3):547-57.
98 Salsano et al. (2012) Orphanet J Rare Dis 7:10.
99 Park et al. (2012) Gene 498(1):131-3.
100 dos Santos Pereira et al. (2012) PLoS ONE 7(3):e34195
101 Lecumberri et al. (2012) J Am Acad Dermatol 66(5):860-1.
102 Engelen et al. (2011) J Peripher Nerv Syst 16(4):353-5.
103 Inoue et al. (2012) Intern Med 51(11):1403-6.
104 Amorosi et al. (2012) Plos One 7(12):e52635.
105 Horn et al. (2013) Pediatr Neurol 48(3):212-9
106 Kallabi et al. (2013) Neurodegener Dis 12(4):207-11.
107 Zhan et al. (2013) Eur J Med Genet 56(7):375-8.
108 Niu et al. (2013) Gene 522(1):117-20
109 Morita et al. (2013) JIMD Rep 10:95-102.
110 Finsterer et al. (2013) Gene 530(1):155-7.
111 Park et al. (2014) Yonsei MJ 55(3):676-82
112 Chen et al. (2014) Gene 544(2):248-51.
113 Triantafyllou et al. (2014) Pediatr Neurol 50(6):622-4.
114 Durmaz et al. (2014) Metab Brain Dis 29(3):809-12.
115 Sutovský et al. (2014) Neuro Endocrinol Lett 35(5):411-6.
116 Jwa et al. (2014) Korean J Pediatr 57(9):416-9.
117 Cai et al. (2014) J Pediatr Endocrinol Metab 28(5-6):725-9.
118 Kallabi et al. (2015) Neurosci Res 97:7-12.
119 Pediatrics Research & Genetics Laboratory, Department of Pediatrics, Maulana Azad Medical College & Associated Lok Nayak Hospital, New Delhi, India. S. Kumar, A. Lomash, S. Kapoor. Contact person: Somesh Kumar (PhD Scholar) (e-mail: someshsloane@gmail.com). Unpublished data
120 Jiang et al. (2015) Metab Brain Dis 30(6):1439-44.
121 Suryawanshi et al. (2015) Endocrinol Diabetes Metab Case Rep 150098.
122 Karkar et al. (2015) BMC Neurol 15:244.
123 Bouquet et al. (2015) Neurology 85(22):1991-3
124 Guran et al. (2015) J Clin Endocrinol Metab 101(1):284-92
125 Chu et al. (2015) World J Pediatr 11(4):366-73.
126 İncecik et al. (2014) Turk J Pediatr 56(6):651-3.
127 Traficante et al. (2015) Clin Case Rep 3(7):643-5.
129 Kallabi et al. (2015) Clin Chim Acta 453:141-6.
130 Koutsis et al. (2015) J Neurol Sci 355(1-2):199-201
131 Horn et al. (2016) Clin Case Rep 4(2):177-81.
132 Ping et al. (2006) Beijing Da Xue Xue Bao 38(1):66-70.
133 Guettsches et al. (2010) J Neurol 257(8):1394-5.
135 Hung et al. (2013) Pediatr Neurol 49(3):185-90.
136 Jack et al. (2013) Case Rep Neurol Med 491790.
137 Ping et al. (2007) Zhonghua Er Ke Za Zhi 45(3):203-7.
138 Karimzadeh et al. (2016) Iran J Child Neurol 10(1):61-4.
139 Schackmann et al. (2016) Mol Genet Metab 118(2):123-7.
140 Kallabi et al. (2016) Biochem Cell Biol 94(3):265-9.
141 Engelen et al. (2014) Brain 137(Pt 3):693-706.
142 Wang et al. (2016) Sci Report 6:35936.
143 Green et al. (2016) Pract Neurol 17(1):71-73.
144 The variant p.Gly528Ser was identified in a whole exome sequencing analysis. Biochemical testing revealed no elevated VLCFA. Personal communication Dr. Vikram Shakkottai, University of Michigan, Ann Arbor, US
145 Laboratory of Molecular Medicine, Unit of Neuromuscular and Neurodegenerative Disorders, Bambino Gesu’ Children’s Research Hospital, Rome, Italy. Contact person: Chiara Aiello, PhD (phone: +390668592103). Unpublished data
146 Kemp et al. (1996) J Inherit Metab Dis 19(5):667-74.
147 Jorge et al. (1996) Ann N Y Acad Sci 804:756-9.
148 Vorgerd et al. (1995) J Neurol Neurosurg Psychiatry 58(2):229-31.
149 Kang et al. (2014) Yonsei Med J 55(4):1157-60.
150 Shukla et al. (2011) Clin Chim Acta 412 (23-24):2289-95
151 Rowland et al. (1996) N Z Med J 109(1028):312-5.
152 Guimarães et al. (2001) Hum Genet 109(6):616-22.
153 Nascimento et al. (2012) BMJ Case Rep pii: bcr2012006308.
154 Habekost et al. (2014) Orphanet J Rare Dis 9:6.
155 Mehrpour et al. (2016) J Mol Genet Med 10(2).
156 Chen et al. (2017) PLoS One 12(5):e0177296.
157 Horikawa et al. (2017) Neuro Endocrinol Lett 38(1):13-18.
158 Maier et al. (2002) Ann Neurol 52(5):683-8.
159 Margoni et al. (2017) J Clin Neurosci pii: S0967-5868(17)30413-7.
160 Dunkl et al. (2016) J Neurol Sci. 367:81-2.
161 Jacob et al. (2015) Child Neurol Open. 2(4):2329048X15609606.
162 Ohkuma et al. (2014) Neuroophthalmology. 38(6):331-335.
163 Ogaki et al. (2016) Neuropathology. 36(1):64-76.
164 Brownstone et al. (2013) Gene. 513(1):71-4.
165 Cappa et al. (2012) J Inherit Metab Dis. 35(5):899-907.
166 Hershkovitz et al. (2002) Ann Neurol. 52(2):234-7.
167 Ke et al. (2010) Neuropediatrics. 41(3):151-3.
168 Larner AJ (2003) J Neurol. 250(10):1253-4.
169 Lesca et al. (2005) Arch Pediatr. 12(8):1237-40.
170 Lledo et al. (2007) Fertil Steril. 88(5):1327-33.
171 Schonberger et al. (2007) Arch Neurol. 64(5):651-7.
172 Thibert et al. (2012) JIMD Rep. 3:79-82.
173 Wang et al. (2013) PLoS One. 8(3):e57977.
174 Wang et al. (2010) Neurol Res. 32(7):695-9.
175 Jung et al. (2007) Neurology. 68(12):960-1.
176 Imamura et al. (1996) Prenat Diagn. 16(3):259-61.
177 Korenke et al. (1996) Pediatr Neurol. 15(2):103-7.
178 Korenke et al. (1997) Eur J Endocrinol. 137(1):40-7.
179 Vorgerd et al. (1995) J Neurol Neurosurg Psychiatry. 58(2):229-31.
180 Wilichowski et al. (1998) Ann Neurol. 43(6):835-6.
181 Molecular Diagnostics Laboratory, University of Minnesota Medical Center, Minnesota (USA). Contact person: K. Wiens (e-mail: kwiens2@Fairview.org). Unpublished data
182 López Úbeda et al. (2017) Arch Argent Pediatr. 115(5):e279-e281.
183 Tsuboi et al. (2017) J Neurol Sci. 381:107-109.
184 Serra Soler et al. (2017) Endocrinol Diabetes Nutr. 64(8):458-459.
185 Son et al. (2017) Stem Cell Res. 25:46-49.
186 Istituto Neurologico C. Besta, via Celoria 11, 20133 Milano, Italy. Contact person: Dr. Ettore Salsano (e-mail: Ettore.Salsano@istituto-besta.it). Unpublished data

Back to information

Last modified | 2017-11-18